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ABSTRACT 
Norman Yeh 
 
TRANSCRIPTION FACTOR REQUIREMENTS FOR THE DEVELOPMENT AND 
ANTI-VIRAL FUNCTION OF IL-17-SECRETING CD8 T CELLS 
 
Inflammatory immune responses are regulated by T cell subsets that secrete 
specific panels of cytokines. While CD8+ T cells that secrete IFN- and cytotoxic 
molecules (Tc1 cells) are known to mediate antiviral immunity, IL-17-secreting 
CD8+ T (Tc17) cells have only recently been described and the development and 
function of these cells has not been clearly examined. Using in vitro T cell 
cultures and mice deficient in transcription factors regulating lineage 
development, we defined Tc17 development and function.  Similar to IL-17 
secretion from CD4 T cells, IL-17 secretion from Tc17 cells is dependent on the 
transcription factor Stat3 and inhibited by Stat1.  Expression of transcription 
factors important for Tc1 function, T-bet and Eomesodermin (Eomes), is reduced 
in Tc17 cells and consistent with this, Tc17 cells are non-cytotoxic in vitro. 
However, Tc17 cells are unstable and switch to cytotoxic IFN- producing cells 
when exposed to a Tc1 inducing cytokine, IL-12.  Overexpression of the lineage 
promoting transcription factors T-bet and Eomes is unable to induce a Tc1 
phenotype in Tc17 cells and Stat3 is also unable to switch Tc1 cells into Tc17 
cells, suggesting additional signals are involved in CD8 T cell lineage 
commitment.  In vivo, Tc17 cells are induced by vaccinia virus, dependant on 
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Stat3, and are capable of mediating antiviral immunity.  Tc17 cells acquire an 
IFN--secreting phenotype after encounter with virus in vivo, however, viral 
clearance by Tc17 cells is independent of IFN-.  Instead, viral clearance is 
correlated with a gain in T-bet expression and cytotoxic function in Tc17 cells 
which have encountered virus.  The development of anti-viral activity 
independent of IFN-, suggests that Tc17 cells may mediate anti-viral immunity 
through novel mechanisms that depend on the ability of Tc17 cells to acquire 
other phenotypes. 
 
 
 
 
 
                                                                                 Mark H. Kaplan, Ph.D.-Chair 
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INTRODUCTION 
Innate and adaptive immune systems 
Despite constant exposure to microorganisms in the environment, we rarely 
become sick due to protective epithelial barriers and our innate and adaptive 
immune systems.  Pathogens that break through skin or mucosal surfaces are 
quickly detected by innate immune cells which are capable of directly killing the 
pathogen and also activating adaptive immune cells to amplify the immune 
response.   
 
Innate immune cells constitute the first line of host immune defense and include 
phagocytes (macrophages, neutrophils, dendritic cells), granulocytes 
(neutrophils, eosinophils, mast cells, basophils), natural killer (NK) cells, and  T 
cells.  Phagocytes contain receptors for many common pathogen associated 
molecular patterns (PAMPs) allowing them to recognize general pathogen 
macromolecules.  Macrophages are widely distributed in body tissues and are 
the first immune cell to encounter pathogens.  Macrophages form reactive 
oxygen species (ROS) to potently destroy engulfed pathogens and are reinforced 
by the arrival of neutrophils from the blood.  Neutrophils are the most numerous 
component of the innate immune response and function as both phagocytes and 
as granulocytes, which secrete antimicrobial granules from their cytoplasm.  
Another phagocytic cell located in tissues is the dendritic cell which is specialized 
to process and display antigens to the adaptive immune system.  Dendritic cells, 
along with macrophages and B cells compose the professional antigen 
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presenting cells (APCs) which activate T cells to become armed effector cells 
(Janeway and Medzhitov, 2002; Murphy et al., 2008).   
 
Other innate cells are associated with fighting more specific classes of 
pathogens.  Eosinophils, mast cells and basophils are important for immunity 
against parasites and contribute to allergic responses.  NK cells attack and 
destroy virus infected cells and tumor cells expressing low levels of surface major 
histocompatibility complex (MHC) class I.   T cell function is still unclear; 
however they are especially localized to the gut mucosa compared to other 
lymphoid tissue suggesting they may be important players at this site (Murphy et 
al., 2008).   
 
In addition to providing the first line of immune defense, activated innate immune 
cells amplify the immune response by priming helper CD4 T cells, cytotoxic CD8 
T cells, and B cells of the adaptive immune system at the site of infection or in 
secondary lymphoid organs.  Activation of T cells requires two signals from the 
same APC – one provided by a MHC molecule presenting a specific antigen to 
the T cell receptor, and the second signal provided by a costimulatory B7 
molecule activating the T cell CD28 receptor.  Activated helper T cells can then 
induce B cell proliferation and class switching and also help activated CD8 T 
cells proliferate and transition into memory cells.  The cellular and humoral arms 
of the adaptive immune system provide both specific and long term protective 
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immunity to reinfection by the same pathogen (Janeway, 2001; Murphy et al., 
2008).   
 
The importance of the innate and adaptive immune system is illustrated by 
diseases where immune cells are deficient or functionally impaired.  For 
example, people with chronic granulomatous disease have impaired production 
of ROS from phagocytes and cannot kill engulfed microorgansims.  They often 
have recurrent bacterial and fungal infections.  In addition, a deficiency in B and 
T cells characterizes one of the most common forms of severe combined 
immune deficiencies (SCID).  People with SCID are highly susceptible to  
bacterial, viral, and fungal infections (Murphy et al., 2008).  
 
T helper cell subsets 
MHC class II molecules display antigens from pathogens multiplying in 
cytoplasmic vesicles and ingested from extracellular fluid to activate naïve CD4 T 
helper cells.  Upon antigen stimulation, naïve CD4 T cells differentiate into at 
least three proinflammatory subsets – Th1, Th2, and Th17 depending on the 
strength of the MHC:TCR interaction, the costimulators used to drive the 
response, and the cytokines present in the environment.   These subsets 
mobilize different arms of the immune system and are characterized by their 
pattern of cytokine secretion – Th1 cells secrete IFN- and lymphotoxin- and 
are important for cell mediated immunity against intracellular pathogens, while 
Th2 cells produce IL-4, IL-5, and IL-13 to mediate humoral immune responses 
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against extracellular bacteria and parasites (Murphy and Reiner, 2002).  Th17 
cells secrete IL-17A, IL-17F, IL-21, and IL-22 to induce inflammation and 
promote cell mediated antibacterial and antifungal immunity (Weaver et al., 
2007).  T helper cell function is tightly regulated to provide optimal host defense 
and can lead to pathological immune responses if they are not properly regulated 
or if they are activated against self proteins.  Chronic Th2 cells contribute to 
asthma and allergies while Th1 and Th17 cells can lead to autoimmune diseases 
(Ouyang et al., 2008).  
 
Transcription factor requirements of T helper cell subsets 
The local cytokine microenvironment induces specific transcription factors in an 
activating T cell to promote T helper development.  Activation of signal 
transducer and activator of transcription (STAT) proteins induce lineage specific 
master regulators and together orchestrate the differentiation of CD4 T cells.  In 
addition to promoting characteristic cytokine secretion, these factors regulate the 
expression of cytokine receptors on the surface of the T cell and inhibit other 
transcription factors to maintain and stabilize T cell lineages.   
 
For Th1 development, two major pathways are essential – IL-12 (derived from 
activated APCs)  Stat4  IFN- (Kaplan et al., 1996a; Magram et al., 1996; 
Thierfelder et al., 1996) and an autocrine IFN- pathway, IFN-  Stat1  T-bet 
 IFN- (Durbin et al., 1996; Szabo et al., 2000; Afkarian et al., 2002).  Stat4 and 
Stat1 proteins are critical for direct induction of IFN- as well as upregulation of T-
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bet.  The IL-12 specific receptor subunit, IL12R2, is expressed at low levels in 
naïve CD4 T cells and is induced by T-bet to augment Th1 development 
(Afkarian et al., 2002).  Th2 development is dependent on the IL-4  Stat6  
GATA-3  IL-4 (Kaplan et al., 1996a; Zheng and Flavell, 1997) pathway.  The 
original source of IL-4 is unknown and GATA-3 is able to autoactivate its own 
expression in a Stat6-independent fashion to maintain Th2 commitment (Zheng 
and Flavell, 1997).  The Th1 and Th2 lineages are stabilized by positive feedback 
loops with IFN- and IL-4 respectively and also by inhibition of the other lineage – 
GATA-3 inhibits Stat4 activation (Usui et al., 2003) and IL12R2 upregulation, 
while T-bet inhibits GATA-3 expression and function.  In addition, the IFN- 
signaling pathway potently inhibits Th17 development.   
 
Development of Th17 cells occurs in three steps – induction, amplification, and 
maintenance (Ivanov et al., 2007).  Induction requires both the anti inflammatory 
cytokine TGF and the acute phase cytokine IL-6 (Bettelli et al., 2006; Mangan et 
al., 2006; Veldhoen et al., 2006) and signals through a TGF + IL-6  Stat3  
RORt  IL-17 pathway (Ivanov et al., 2006; Mathur et al., 2007; Yang et al., 
2007a).  At the same time, TGF + IL-6 induces IL-21 which combines with TGF 
in a feedforward loop to amplify Th17 development and upregulate IL23R.  IL-21 
induction is STAT3 dependant and TGF + IL-21 also signal through Stat3 and 
RORt (Wei et al., 2007).  Finally, IL-23 signals through Stat4 in addition to Stat3 
to maintain Th17 development (Mathur et al., 2007).  
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Stability of T helper cell subsets 
T helper cell differentiation has been described as a terminal process leading to 
the development of subsets expressing mutually exclusive cytokine profiles 
(Ansel et al., 2003; Rowell and Wilson, 2009; Zhou et al., 2009).  Early studies 
demonstrated that Th1 and Th2 cells are committed to their respective lineages 
after multiple rounds of stimulation (Murphy et al., 1996).  However, observations 
of cells coexpressing IL-17 and IFN- in vivo have questioned T cell commitment 
(Mangan et al., 2006; Korn et al., 2007; Suryani and Sutton, 2007).  In vitro, Th17 
cells contain chromatin modifications at Th1 and Th2 transcription factors 
suggestive of a poised state ready for subsequent silencing or activation and  
transition into opposite lineages (Wei et al., 2009).  Consistent with this, Th17 
cells have the capacity to switch to Th1 and Th2 cells upon challenge with 
instructive cytokines of either lineage (Lexberg et al., 2008; Stritesky et al., 2008; 
Lee et al., 2009).  These data have raised new questions about T cell stability 
and the relationship between T helper lineages during an ongoing immune 
response.  
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Figure 1. T helper cell development.  Naive T helper precursors (Thp) 
differentiate into CD4 T cell subsets depending on cytokines in the environment 
and transcription factors activated.  TGF + IL-6 activate Stat3 and Rort to 
promote Th17 development with IL-23 maintaining the Th17 lineage.  IL-12 
activates Stat4 and IFN activates Stat1 and T-bet to promote Th1 development.  
IL-4 activates Stat6 and GATA-3 to promote Th2 development.   
 
Cytotoxic T Lymphocytes 
Function and memory formation 
CD8 T cells respond to an acute infection through three phases - (1) activation, 
(2) contraction, and (3) memory formation.  During the activation phase, 
pathogen specific CD8 T cells recognize intracellular antigens presented by MHC 
class I molecules and expand several fold, sometimes accounting for up to 50% 
of the total CD8 T cells at the peak of the response (Butz and Bevan, 1998).  
Activating CD8 T cell populations upregulate multiple effector proteins – perforin 
and granzymes (both contained in granules) and surface expression of Fas 
Ligand to become effector cytotoxic T lymphocytes (CTLs).  Perforin allows 
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granzymes to traffic into target cells and induce apoptosis through caspase 
cleavage and by releasing apoptotic factors from the mitochondria.  Fas ligand 
can also induce caspase cleavage after binding to the Fas receptor.  CTLs 
therefore induce apoptosis and also secrete IFN- to mediate antiviral immunity 
and tumor immunosurveillance (Russell and Ley, 2002). 
 
In the subsequent contraction phase, 90-95% of these effector CD8 T cells 
undergo apoptosis.  The remaining 5-10% of the CD8 T cells specific for the 
pathogen enter the memory pool and, following reexposure to the pathogen, 
undergo a rapid recall response to quickly expand and acquire effector function.  
In humans, memory CD8 T cells have been observed for up to 75 years after 
vaccination, presumably providing lifelong immunity in some instances 
(Hammarlund et al., 2003).  The magnitude of the CD8 T cell response and the 
number of memory cells generated can be modulated by several factors 
including antigen availability, inflammatory stimuli, and CD4 T cell help (Williams 
and Bevan, 2007; Harty and Badovinac, 2008; Murphy et al., 2008).   
 
Subsets 
Activation in the presence of various proinflammatory cytokines, however, can 
alter the innate CTL programming of CD8 T cells and lead to at least three 
proinflammatory subsets characterized by their panel of secreted cytokines – 
Tc1, Tc2, and Tc17, analogous to CD4 T helper cell subsets (Carter and Dutton, 
1996; Mosmann and Sad, 1996; Liu et al., 2007).  IL-12 augments innate CD8 T 
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cell programming to increase expression of IFN- and cytotoxic molecules and 
induce Tc1 development (Croft et al., 1994).  IL-4 diverts innate CD8 T cell 
programming to develop Tc2 cells expressing IL-4, IL-5, IL-13 and reduced 
amounts of IFN- (Seder et al., 1992; Kelso and Groves, 1997).  The Tc17 subset 
develops in the presence of TGF and IL-6 and is characterized by secretion of 
IL-17A, IL-17F, IL-21, and IL-22 (Intlekofer et al., 2008; Ciric et al., 2009; Curtis 
et al., 2009; Hamada et al., 2009; Huber et al., 2009). 
   
The role of Tc1 cells in delayed type hypsersensitivity (DTH) reactions and 
helping the immune system eradicate tumors and viruses is well established.  In 
addition, putative roles for Tc2 and Tc17 cells in these traditional Tc1 functions 
have been suggested.  Similar to Tc1 cells, Tc2 cells are antitumor in an in vivo 
tumor metastasis model (Dobrzanski et al., 1999), and recruit inflammatory 
effector cells to a DTH reaction.  However, the mechanisms by which Tc1 and 
Tc2 cells operate may differ.  In cell mediated cytotoxicity, both utilize the perforin 
pathway while Tc1, but not Tc2 cells, display significant lysis through Fas-
mediated pathways (Carter and Dutton, 1995).  In a metastatic melanoma model, 
Tc1 cells kill the tumor directly while Tc2 cells chemoattract host IFN- secreting 
cells to fight the tumor (Dobrzanski et al., 2001).   
 
IL-17 secreting cells have a controversial role in tumor immunity which could 
depend on the level of IL-17 in the environment.  Tumors secrete large quantities 
of TGF- and tumor bearing mice have greater numbers of Th17 and Tc17 cells 
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(Kryczek et al., 2007b).  A study has demonstrated that IL-17 secreting T cells 
promote tumor survival (Nam et al., 2008), however adoptive transfer of Tc17 
cells clears tumor in a melanoma model (Hinrichs et al., 2009).  Tc17 cells have 
also been shown to be antiviral in an influenza virus model.  In this model, Tc17 
cells are induced and clear virus in a perforin independent and IFN- dependant 
mechanism (Hamada et al., 2009).   
 
Tc17 cells are also induced or correlated with several allergic or autoimmune 
diseases.  IL-17 secreting CD8 T cells are critical for the elicitation of contact 
hypersensitivity CHS) (He et al., 2006).  CD8 T cell clones from psoriatic lesions 
can express IL-17 (Teunissen et al., 1998).  Active lesions in multiple sclerosis 
contain a high numbers of Tc17 and Th17 cells (Tzartos et al., 2008; Goverman, 
2009).  Autoreactive Tc17 and Th17 cells are also induced in experimental 
autoimmune uveitis (Peng et al., 2007).  In addition, IL-6-driven expansion of 
Tc17 cells induces colitis (Tajima et al., 2008).   
 
Collectively, these reports suggest that CD8 T cell subsets are able to clear 
tumors and intracellular pathogens most likely utilizing unique mechanisms.  In 
addition, IL-17 secreting CD8 T cells may be involved in Th17 related host 
immunity and autoimmune diseases.    
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Transcription factor requirements of T cytotoxic cell subsets 
Important TCR induced proteins for development of cytolytic effector cells include 
the related T-box factors T-bet and Eomes.  Pre-existing Runx3 also plays a 
critical role in CTL development and a deficiency in any of these factors 
diminishes effector function (Taniuchi et al., 2002; Pearce et al., 2003; Sullivan et 
al., 2003). Based on overexpression studies, gene deficient cells, and expression 
kinetics, a two stage model has been proposed where T-bet is necessary for 
early development and Runx3  Eomes signals are important for late CTL 
function (Cruz-Guilloty et al., 2009).  This innate CTL programming is altered by 
cytokines in the microenvironment to develop T cytotoxic cell subsets utilizing 
similar signaling pathways which drive T helper cell subsets.   
 
IL-12  STAT4  T-bet signals (Takemoto et al., 2006) augment CTL 
programming to induce Tc1 cells (Curtsinger et al., 1999; Curtsinger et al., 2003) 
and further upregulate IFN- (Li et al., 2006) and cytotoxic molecules (Curtsinger 
et al., 2005).   Interestingly, IL-12 represses Eomes expression as it augments 
CTL programming (Takemoto et al., 2006).  T-bet induction through IL-12  
STAT4 signals contrasts to CD4 T cells where T-bet is regulated through IFN- 
 STAT1 pathways and is possibly due to higher induction of IL12R2 in CD8 T 
cells leading to increased sensitivity of CD8 T cells to IL-12 (Yang et al., 2007b).  
STAT1 does not appear to play a role in Tc1 development (Casey and Mescher, 
2007) where the main function described of STAT1 is for CD8 T cell clonal 
expansion and memory formation (Gil et al., 2006; Quigley et al., 2008).   
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Tc2 cells develop via the same IL-4  Stat6  GATA3 (Kaplan et al., 1999; 
Omori et al., 2003; Yamaguchi et al., 2004) signaling pathway utilized to drive 
Th2 development and can secrete similar levels of IL-5 and IL-13 as Th2 cells.  
However, IL-4 production (Croft et al., 1994) and histone hyperacetylation at the 
IL-4 gene locus is much lower in Tc2 cells.  This is proposed to be due to 
decreased GATA-3 expression and increased expression of an inhibitor of 
GATA-3 function, ROG (Repressor of GATA) compared to Th2 cells (Omori et 
al., 2003).     
 
Cytokines and transcription factors determining Tc17 development also appear 
identical to those involved in Th17 development.  The combination of TGF and 
either IL-6 or IL-21 induces the generation of Tc17 cells (Stumhofer et al., 2006; 
Liu et al., 2007) through a Stat3  RORt pathway.  IL-23 can also induce IL-17 
secretion from Tc17 cells and has been shown to induce the secretion of IL-17 in 
naïve CD8 T cells in contrast to its actions on naïve CD4 T cells (Vanden Eijnden 
et al., 2005).  The IFN-  Stat1 pathway in addition to T-bet and Eomes 
strongly inhibit Tc17 development (Intlekofer et al., 2008; Ciric et al., 2009).   
 
CD8 T cell subsets develop in a similar fashion as CD4 T cell subsets.  However, 
the extent of polarization and the amount of cytokines secreted between 
respective CD8 and CD4 T cell subsets often differ due to preferential expression 
of certain transcription factors in naïve CD8 vs CD4 T cells (Runx3, Eomes) and 
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differential upregulation of lineage specific transcription factors (ROG) and 
cytokine receptors (ie. IL12R2).   
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Figure 2. T cytotoxic cell development.  Naive T cytotoxic precursors (Tcp) 
differentiate into CD8 T cell subsets depending on cytokines in the environment 
and transcription factors activated.  TGF + IL-6 activate Stat3 and Rort to 
promote Tc17 development and IL-23 contributes to Tc17 formation.  IL-12 
activates Stat4 and T-bet to promote Tc1 development.  IL-4 activates Stat6 and 
GATA-3 to promote Th2 development.   
 
Antiviral Immunity 
The life cycle of a virus can be described in four stages –  
1. Viral attachment and entry into a host cell. 
2. Migration into the appropriate cellular compartment.   
3. Transcription and translation of the viral genome for viral replication. 
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4. Assembly and release of mature virions to reinfect additional cells.  
Host immune responses interfere with each stage to promote antiviral immunity 
through cytolytic and non-cytolytic mechanisms.   
 
Upon viral detection, the innate immune system produces high levels of Type I 
Interferons (IFN- and IFN-) to promote an antiviral state both directly, by 
inhibiting viral replication, and indirectly by activating the innate and adaptive 
immune systems.  IFN- and IFN- can stimulate effector functions of NK cells, 
CTLs, and macrophages as well as induce MHC class I and MHC class II to 
increase immunogenicity of infected cells.  NK cells are important for early viral 
control and kills either infected cells before MHC class I is upregulated or 
infected cells which normally express no or low levels of MHC class I.  NK cells 
can also mediate noncytolytic control of viral infections by secreting cytokines 
such as IFN- and TNF-.   
 
Antigen presentation and clonal expansion of the adaptive immune response 
occurs over several days after which CD8 T cells, CD4 T cells, and B cells all 
play important roles in viral control.  Similar to NK cells, CD8 T cells mediate viral 
clearance by killing infected cells and by producing IFN- and TNF-.  B cells 
produce neutralizing antibodies to prevent viral reinfection of additional cells or 
viral infection during a memory response.  CD4 T cells produce IFN- and help 
memory formation of CD8 T cells and antibody isotype switching from B cells.  
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Immune response to vaccinia virus  
Upon infection with vaccinia virus, NK cells (Bukowski et al., 1983; Stitz et al., 
1986) and  T cells (Selin et al., 2001) contribute to vaccinia clearance. Vaccinia 
virus infection also induces an adaptive immune response which precedes viral 
clearance.  This response peaks about a week after infection in mice and 
includes clonal expansion of CD4+ and CD8+ T cells and virus specific 
antibodies.  CD4 T cells and B cells have a critical role in vaccinia clearance (Xu 
et al., 2004), while CD8 cells contribute to viral clearance during a memory 
response or in the absence of CD4 T cells (Xu et al., 2004).  Inoculation with as 
few as 10 pfu of vaccinia virus leads to generalized vaccinia infection and death 
in athymic nude mice illustrating the importance of T cells in vaccinia clearance 
(Muller et al., 1994).  Effects of antibody depletion or genetic deficiency of 
important antiviral factors are summarized in Table 1.   
 
The role of IL-17 in vaccinia virus clearance is unclear.  A recombinant vaccinia 
virus overexpressing IL-17 has been shown to have both increased (Patera et al., 
2002) and decreased (Kohyama et al., 2007) viral load in an infected mouse.  A 
role for IL-17 in vaccinia survival is supported by a report demonstrating IL-17 
inhibition of NK cell function (Kawakami et al., 2009), while a role for IL-17 in 
vaccinia clearance is suggested in a study demonstrating increased vaccinia 
virus induced mortality in Il17 deficient mice (Kohyama et al., 2007).   
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IL-17 has also been shown to play a role in other viral infection models.  IL-17 
was first cloned and described from a homologous gene in Herpesvirus Samirii 
(Yao et al., 1995).  Deficiency of this gene does not affect H. samirii replication 
and is thought to be involved in apathogenic viral persistence in its host (Arens et 
al., 2008).  IL-17 is induced after infection with several viruses including HIV 
(Maek et al., 2007), murine CMV (Arens et al., 2008), and influenza (Hamada et 
al., 2009).  In a model of Theiler’s murine encephalomyelitis virus infection, IL-17 
enhances viral survival by upregulating antiapoptotic molecules (Hou et al., 
2009).  In contrast, IL-17 enhances viral killing in an influenza model (Hamada et 
al., 2009; McKinstry et al., 2009) suggesting that the function of IL-17 in viral 
immunity may be virus specific.   
Table 1. Immune cell and antiviral effector requirements for immunity 
against vaccinia virus.   
Cell Type NK cells  T cells CD8 T cells  
CD4 T 
cells B cells 
Requirement 
for primary 
VV clearance 
+ + - + + 
Reference 
(Bukowski et 
al., 1983; Stitz 
et al., 1986)  
(Selin et al., 
2001)  
(Spriggs et al., 
1992; Xu et al., 
2004)  
(Xu et al., 
2004)  
(Xu et al., 
2004)  
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Effector 
Mechanism IFN-R IFN-R IFN- Perforin Fas Ligand 
Requirement 
for primary 
VV clearance 
+ + + - - 
Reference (Muller et al., 1994)  
(Huang et al., 
1993; Muller et 
al., 1994; 
Cantin et al., 
1999)  
(Cantin et al., 
1999)  
 (Kagi et al., 
1995) 
 (Kagi et al., 
1995) 
 
Research Goals 
In the past decade, IL-17 has been shown to play a critical role in antibacterial 
and antifungal immunity and also to contribute to several autoimmune diseases 
such as multiple sclerosis and rheumatoid arthritis.  IL-17 production and 
regulation has mostly been studied in CD4 T helper cells and its role from CD8 T 
cytotoxic cell has not been conclusively established.  Therefore, the goal of this 
research is to determine IL-17 regulation from CD8 T cells and its role in CD8 T 
cell immunity. 
 
Several reports have shown the existence of Tc17 cells; however, cytokines and 
transcription factors regulating their development have not been studied as 
extensively as factors regulating development in Th17 and IFN- secreting CD8 T 
cells.  We wanted to examine the role of cytokines and important downstream 
Th17 and Tc1 transcription factors in Tc17 development utilizing in vitro T cell 
cultures and mice deficient in transcription factors regulating lineage 
development.  
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To determine the role of Tc17 cells in antiviral immunity, we utilized a vaccinia 
virus infection model and gene deficient mice with either defective or enhanced 
IL-17 production.  In addition, adoptive transfer of in vitro generated IL-17-
secreting CD8 T cells was utilized to determine the antiviral potential of Tc17 
cells.  
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MATERIALS AND METHODS 
 Mice   
The generation of Stat4-/- (Kaplan et al., 1996b), Stat1-/- (Meraz et al., 1996) 
(Taconic Farms, Germantown, NY), Tbx21-/- (Szabo et al., 2000), Stat3fl/fl mice 
with a CD4-Cre transgene (Stat3CD4-/-) (Raz et al., 1999; Chiarle et al., 2005), 
Ifng-/- (Dalton et al., 1993) (Jackson Laboratories, Bar Harbor, ME) and Il17-/- 
mice (Nakae et al., 2002) were previously described.  All mice were on a 
C57BL/6 background except for Stat1-/- mice which were on a 129S6 background 
and Il17-/- mice which were on a Balb/c background.  C57BL/6 and Balb/c mice 
were purchased from Harlan Bioscience (Indianapolis, IN), 129S6 and OT-I / 
Rag1-/- mice were purchased from Taconic Farms, C3H/HeJ mice were 
purchased from Jackson Laboratories and BoyJ mice were purchased from the 
IU Simon Cancer Center In Vivo Therapeutics Core (Indianapolis, IN).  Mice were 
kept in pathogen-free conditions and all studies were approved by the Indiana 
University School of Medicine Animal Care and Use Committee. 
 
Viruses 
VV (Western Reserve strain) and VV-SIINFEKL was generated in the human 
osteosarcoma TK-143B cell line, followed by sucrose purification and titer 
determination by the Poxvirus Core Facility at Indiana University School of 
Medicine as described (Li et al., 2005).  
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T cell and APC Isolation 
Spleen and inguinal, axillary, brachial, and mesenteric lymph nodes were 
collected from mice and single cell suspensions were made in RPMI 1640 
(Invitrogen, Carlsbad, CA) supplemented with 10% fetal bovine serum (Atlanta 
Biologicals, Norcross, GA), 1mM glutamine, 100 Units/ml penicillin, 100 g/ml 
streptomycin, 10 mM Hepes buffer, 0.5 x nonessential amino acids, 1mM sodium 
pyruvate (all from BioWhitaker, Walkersville, MD), and 50 M -mercaptoethanol 
(Sigma, St. Louis, MO).  Cell suspensions were transferred into a 50 mL conical 
tube through a strainer (BD Biosciences, San Jose, CA) to remove debris.  The 
cells were centrifuged at 1,500 rpm for 5 minutes at 4°C and the supernatant was 
discarded.  Cell pellets were resuspended in 4-5 mL of red blood cell (RBC) lysis 
buffer (8.3 g/L NH4Cl in 0.01 M Tris-HCl; pH: 7.5) and incubated for 1-2 minutes 
at room temperature.   After RBC lysis, 5 mL of phosphate buffered saline (PBS) 
were added and samples were centrifuged at 1,500 rpm for 5 minutes at 4°C.  
Cell pellets were washed once in MACS Buffer (2mM EDTA and 0.5% bovine 
serum albumin (BSA) in PBS) and re-suspended in 900 l of MACS buffer per 
spleen.  Total CD4+ and CD8+ cells were isolated by positive selection according 
to manufacturer’s protocol with magnetic beads  (magnetic cell sorting [MACS] 
isolation system; Miltenyi Biotec, Auburn, CA).  CD45.2+ cells were isolated by 
incubating with 25 l anti-CD45.2 PE per spleen for 15 minutes, washing two 
times with MACS buffer, and then incubating with 25 l anti-PE microbeads per 
spleen for an additional 15 minutes.  In other experiments, APC’s were obtained 
by collecting the flow through of cells from the column after positive selection.  
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APCs were resuspended in 5 mL of supplemented RPMI media in a 15 mL 
conical tube and irradiated with 3000 rads.  Irradiated APC’s were washed 3 
times with PBS before use in cocultures with T cells.   
 
In vitro T Cell Differentiation 
For Tc cell differentiation, CD8+ cells (0.25x106 cells/ml) were activated with 
soluble anti-CD3 (4 g/ml 145–2C11) and anti-CD28 (1 g/ml; BD Pharmingen) 
in the presence of CD8+ depleted irradiated splenocytes (1:5).  OT-I CD8+ cells 
were activated with soluble SIINFEKL peptide (1M; Bio-Synthesis Inc) and anti-
CD28 (1 g/ml).  Tc17 primed cells were cultured with hTGF1 (2 ng/ml; R&D 
Systems), IL-6 (100 ng/ml; PeproTech), and anti-IFN (10 g/ml R4/6A2 or XMG) 
and Tc1 primed cells were differentiated with IL-12 (5 ng/ml; R&D Systems).  In 
some experiments, CD8+ cells were cultured with IL-21 (50ng/ml; eBioscience) 
or IL-23 (10ng/ml; R&D Systems).  Cells were maintained in 5% CO2 at 37°C.  
After 3 days of incubation, cells were expanded into 25 cm2 flasks in the 
presence of 20 units/ml recombinant hIL-2.  After 2 more days of culture, cells 
were washed, counted and analyzed by RT-PCR, flow cytometry, and ELISA.  
For Th cell differentiation, CD4+ cells (1x106 cells/ml) were activated and 
differentiated with cytokines and neutralizing antibodies at the same 
concentrations as described above.  After 3 days of incubation, cells were 
expanded into larger wells in the presence of 20 units/ml recombinant hIL-2 and 
counted and analyzed after an additional 2 days of culture. 
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In some experiments, cells underwent 2 rounds of stimulation.  For the second 
five days of culture, cells were replated (0.25x106 cells/ml) and stimulated with 
soluble anti-CD3 (1 g/ml) and anti-CD28 (0.5 g/ml) in the presence of CD8+-
depleted irradiated splenocytes (1:5).  OT-I cells were activated with soluble 
SIINFEKL peptide (0.5 M) and anti-CD28 (0.5 g/ml).  Cells were stimulated 
and maintained with the same cytokine and neutralizing antibody concentrations 
as used in the first five days.   
 
Retroviral Vectors and Transductions  
The retroviral vector MIEG-hCD4 was made as previously described (Chang et 
al., 2005) and modified for coexpression of Eomes by digesting the coding region 
of murine Eomes cDNA (Open Biosystems) with EcoRI and NotI and cloning into 
MIEG-hCD4.  Additional vectors MIEG-GFP, Tbet-GFP, MSCV-H2Kk, STAT3C-
H2Kk have been previously described (Mathur et al., 2006; Mathur et al., 2007) 
and RORt-GFP was received from Dr. Gilbert Kersh, Emory University.  
  
Retroviral supernatants were generated by transfecting a Phoenix-Eco packaging 
cell line in chloroquine containing DMEM media with 15 g of purified plasmid by 
calcium phosphate precipitation. Cells were cultured at 37°C and one day after 
transfection, chloroquine containing DMEM media was replaced with fresh 
DMEM media. After 1 more day, the supernatants containing retrovirus were 
collected, filtered through a 0.45 m filter and stored at -80°C.  Wild type CD8+ T 
cells were cultured under the indicated conditions for 24 hours.  Cells were 
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transduced with 4 ml of retroviral supernatant containing 4 g/ml of polybrene, 
and centrifuged at 2000 rpm at 20°C for 1 hr. For double transductions, 3 ml of 
each virus were mixed together for the spin infection. After the centrifugation, the 
retroviral supernatant was replaced with the original conditioned media.  
Transduced cell populations were either restimulated and gated on the selectable 
marker for analysis by ICS or sorted for positively transduced cells and analyzed 
by RT-PCR, flow cytometry, or ELISA assay. 
 
RNA Isolation and cDNA Conversion   
Cells (0.5-1x106) were lysed in Trizol (1 mL) and used immediately or stored at -
80°C.  Lysed cells were incubated for 5 minutes at room temperature before 
adding 200 l of chloroform and shaking vigorously for 15 seconds.  Homogenate 
was incubated at room temperature an additional 2 minutes and then spun at 
12,000g for 15 minutes at 4°C.  The aqueous phase was transferred to a new 
tube and RNA was precipitated by the addition of 0.5 ml isopropanol and 
incubation at -20oC overnight.  The next day, RNA was spun at 12,000g for 10 
minutes and washed one time with cold 75% ethanol before air drying and 
resuspending in 20 l diethylpolycarbonate (DEPC) treated ddH20.  Isolated RNA 
was reverse transcribed into cDNA using the Cloned AMV First-Strand cDNA 
Synthesis Kit (Invitrogen) and random hexamer primers in a 20 l total volume.  
cDNA was then diluted with DEPC ddH20 to a 100 l total volume before using in 
real time RT PCR reactions.  Nuclease-free filtered pipette tips were used for all 
RNA work.  
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Real-Time RT-PCR 
cDNA (5 l) was added to 1.25 l primer (inventoried FAM-labeled TaqMan 
Gene Expression Assays, Applied Biosystems), and 12.5 l Taqman Universal 
PCR Master Mix (Applied Biosystems).  DEPC H20 was added to a final reaction 
volume of 25 l.  Samples were analyzed in duplicate, mixed in 96-well optical 
reaction plates, and capped with optical reaction caps (Applied Biosystems) 
Gene expression was measured on an Applied Biosystems ABI PRISM 7500 
Realtime PCR system.  Cycle number was normalized to 2-microglobulin 
expression.  Data were analyzed using the provided software and cycle threshold 
(Ct) was calculated using the Auto Ct function.   
 
Cell Surface Staining    
Total splenocytes or isolated T cells (0.25-1x106) were placed in 12x75 mm flow 
cytometry tubes.  Following centrifugation at 1,500 rpm for 5 minutes at 4°C, cells 
were washed once in FACS/ELISA buffer (2% BSA, 0.01% NaN3 in PBS) and re-
suspended with formaldehyde at a final concentration of 2% and a total volume 
of 100 l.  Cells were incubated for 10 minutes at room temperature and washed 
twice with FACS/ELISA buffer.  Buffer was removed and purified FcIII/II receptor 
(1 μg per 1x106 cells; BD Biosciences) was added to samples containing APC’s, 
mixed by vortex and incubated at 4°C for 10 minutes.  Cells were surface stained 
for CD4, CD8, CD44, CD122, CD62L, CD45.1, or CD45.2 using fluorochrome 
conjugated antibodies (eBioscience) for 20 minutes at 4°C.  Cells were washed 
one time in 1 mL of FACS/ELISA buffer and permeabilized for intracellular 
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staining or analyzed by flow cytometry on FACS-Calibur machines (BD 
Biosciences).  In each sample 8,000 gated events were collected and data were 
analyzed using WinMDI software.   
 
Intracellular Cytokine Staining   
CD4+ or CD8+ T cells (0.25-1x106) were stimulated with phorbol-myristate 
acetate (PMA) (50 ng/mL; Sigma) and ionomycin (500 ng/ml; Sigma) for 4 hours 
in the presence of GolgiPlug (BD Biosciences).  In some experiments, OT-I cells 
were stimulated with SIINFEKL peptide (1 M) or CD8 cells were stimulated with 
vaccinia virus B8R peptide (1 g/ml) for 4-5 hours in the presence of GolgiPlug.  
Cells were fixed for 10 minutes at room temperature with formaldehyde at a final 
concentration of 2%, stained for surface markers as described above, and 
permeabilized by washing twice with FACS/ELISA buffer plus 0.1% saponin.  
Cells were stained for IL-17, IFN-, IL-2 (eBiosciences) and TNF- (BD 
Biosciences) using fluorescently conjugated antibodies for 30 minutes at 4°C.  
Cells were washed one time in FACS/ELISA buffer plus 0.1% saponin.  Samples 
were analyzed by flow cytometry using FACS-Caliber machines and data were 
analyzed using WinMDI software. 
 
Granzyme B and Transcription Factor Staining 
CD4+ or CD8+ T cells (0.25-0.5x106) were stimulated with PMA (50 ng/mL) and 
ionomycin (500 ng/ml; Sigma) for 4 hours in the presence of GolgiPlug for 
Granzyme B staining or left unstimulated for T-bet, Eomes, Rort, and phospho-
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Stat4 staining.  Cells were collected and fixed for 10 minutes at room 
temperature with formaldehyde at a final concentration of 2%.  Cells were 
pelleted by centrifugation and resuspended in 1 mL of 100% methanol for 10 
minutes at 4oC or overnight at -20°C.  Cells were then washed three times with 2 
mL FACS/ELISA buffer and stained for Granzyme B, T-bet, Eomes and Rort 
using fluorescently conjugated antibodies (eBiosciences) for 30 minutes at 4°C.  
Cells were washed in 1 mL FACS/ELISA buffer and the samples were analyzed 
by flow cytometry using FACS-Calibur machines.  Data were analyzed using 
WinMDI software.  
 
Detection of Cytokines Using ELISA 
To generate cell free supernatants for analysis, T cells differentiated for 5 days 
were washed and stimulated (1x106 CD4+ T cells/ml or 0.25x106 CD8+ T 
cells/ml) with plate bound anti-CD3 (4 g/ml) for 24 hours or freshly isolated 
CD4+ or CD8+ T cells (1x106 CD4+ T cells/ml) were stimulated with plate bound 
anti-CD3 (4 g/ml) for 48-72 hrs.  For antigen specific stimulation, ex vivo 
isolated CD8+ cells were stimulated with 1M SIINFEKL peptide for 48-72 hrs.  
To test for cytokine secretion, 2 g/ml of anti-IFN-, anti-IL-17, anti-IL-21, or anti-
IL-22 capture antibodies were dissolved in 0.1 M NaHCO3 (pH 9) or 2 g/ml of 
anti-IL-10 capture antibody was dissolved in 0.1 M Na2HPO4 (pH 7) and 50 
l/well was used to coat a 96 well Immunosorbent plate.  Plates were incubated 
at 4°C overnight and washed two times in ELISA Wash buffer (0.1% Tween-20 in 
PBS) and blocked for at least two hours at room temperature in FACS/ELISA 
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buffer (100 l/well).  FACS/ELISA buffer was removed and supernatants and 
cytokine standards (R+D Systems) were added and incubated overnight at 4°C.  
Plates were washed four times with ELISA wash buffer and incubated at room 
temperature with 1 g/mL of biotinylated detection antibodies dissolved in 
FACS/ELISA buffer for at least two hours.  Plates were washed four times with 
ELISA wash buffer and incubated with. streptavidin alkaline phosphotase (1:2000 
dilution; Sigma) in FACS/ELISA buffer for at least one hour.  Cytokine levels 
were determined following the addition of Sigma 104 phosphatase substrate (5 
mg/ml; Sigma) dissolved in ELISA substrate buffer (10% diethanoloamine, 0.05 
mM MgCl2, 0.02% NaN3, pH 9.8) by measuring the absorbance at 415 nm (BIO-
RAD microplate reader model 550). 
  
51Cr Release Cytotoxicity Assay 
Cytotoxic activity of OT-I Tc17 and Tc1 effector cells were measured in standard 
51Cr release assays.  EL4 and EG.7 (EL4 cells transfected with chicken 
ovalbumin) target cells were grown in RPMI supplemented with 10%FBS, 1mM 
glutamine, and 10 g/ml gentamycin and split 1:5 the day before the assay.   
 
On the day of the assay, EL4 and EG.7 target cells (6x106) were prepared by 
incubating with 200 Ci of Na2CrO4 (0.04 ml of 5 mCi/ml Chromium-51 
radionuclide solution; Perkin Elmer) for 1 hr at 37°C.  Target cells were incubated 
in a total volume of 1 mL in a 50 mL conical tube for 1 hr at 37°C and washed 3 
times with supplemented RPMI media.   
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Effector cells were added to a round bottom 96-well microtiter plate in triplicate 
and serially diluted three fold to generate effector:target ratios ranging from 30:1 
to 0.03:1.   Next, target cells (100 l, 2x104 cells per well) were added to the 
microtiter plate.  Reactions were conducted in a total volume of 200 l per well.  
Plates were incubated for 6 hrs at 37°C, spun down, and 100 l of supernatant 
was harvested from each well.  Radioactivity was counted in a Perkin Elmer 
gamma counter.  The % specific lysis was calculated as (cpmsample – 
cpmspontaneous)/(cpmmaximum – cpmspontaneous) x 100, where cpm is counts per 
minute.  Spontaneous release represents the radioactivity released by target 
cells in the presence of media alone, and maximum release represents the 
radioactivity released by target cells lysed with 5% Triton X-100.  Spontaneous 
release was less than 20% of the maximum in chromium release assays.   
 
CFSE Cytotoxicity Assay 
In other experiments, cytotoxic activity of OT-I effector cells were measured by 
labeling the target cells with 2 different concentrations of CFSE.  EL4 and EG.7 
target cells were labeled with 1 and 0.01 M CFSE respectively.  Reactions were 
performed in a 96 well round bottom microtiter plate with 50 l labeled EL4 cells, 
50 l labeled EG.7 cells, and 100 l effector OT-I cells.  After 4 hrs of incubation 
at 37°C, cells were collected into 15x75 mm flow cytometry tubes.  7-AAD 
(eBioscience) was added to identify dead cells and reactions were analyzed 
using flow cytometry.  Percentage of antigen specific cytotoxicity was calculated 
by the formula: %cytotoxicity = 100 x [1 – (E.G7/EL4)experimental/(E.G7/EL4)control]. 
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Infections 
For experiments analyzing the effects of genetic deficiencies in VV infection, 2-6 
mice per group were infected intraperitoneally (i.p.) with a sublethal dose (1x106 
or 5x106 pfu/mouse) of VV (WR strain).  Mice were sacrificed after 7 or 11 days 
of infection and ovaries and spleens were collected.  For adoptive transfer 
experiments, 2-5 mice per group were infected either intranasally (i.n.) (2x106) or 
i.p. (2x107) with VV-SIINFEKL.  Infection was performed 1 day before or after cell 
transfer.  Changes in body weight were calculated as the percent body weight on 
the day of measurement minus the percent body weight on the day of infection.  
Mice were sacrificed 4-8 days after infection and spleens, ovaries, and lungs 
were collected.   
 
Adoptive T Cell Transfer 
Purified naïve CD8+ cells (1x106) or 5 day differentiated Tc17 or Tc1 cells 
(1x106) from OT-I mice were transferred via tail vein injection.  Cells were 
transferred in 500 l of PBS using 22G 1” needles and 1 mL syringes.  In some 
experiments, purified cells were labeled with CFSE (Molecular Probes, 
Invitrogen, Carlsbad, CA) according to manufacturers protocol.  Prior to transfer, 
all cells were washed twice in PBS.  
 
VV Titer Assay 
Mice were sacrificed 3-11 days after infection.  Two ovaries or two lungs from 
each mouse were removed and stored in 1 ml of DMEM at -80°C. The day before 
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the assay, CV-1 cells were plated at ~1.7x105 cells/well in a 12 well plate.  On 
the day of the assay, organs were thawed at 37°C and kept on ice.  Organs were 
liquefied in the 1 ml of DMEM they were frozen in using a Tissue-tearor 
homogenizer.  Blades of the homogenizer were sterilized with EtOH before 
beginning, and between each sample blades were rinsed with a 10% bleach 
solution, PBS 2 times, and then DMEM.  6 serial 1:10 dilutions of homogenized 
ovaries in DMEM were made and diluted ovaries were kept on ice.  Plates with 
confluent CV-1 cells were prepared by washing one time with PBS and adding 60 
l of DMEM to each well.  Ovary dilutions were measured in duplicate and 40 l 
of each dilution was added to the plate to make a total volume of 100 l.  Plates 
were incubated at 37°C for 30 minutes with rocking every 5 minutes.  1 mL of 
DMEM supplemented with 10% FCS, penicillin/streptomycin, and 2 mM 
Glutamine was added to each well.  Plates were incubated for an additional 72 
hrs.  After 72 hours, media was removed from the wells and 0.2% Crystal Violet 
(in 20% EtOH) was added to cover the bottom of the wells for 5 minutes.  Wells 
were aspirated and allowed to dry before counting plaques.   
 
Th17 Enrichment 
Th17 cells were activated with plate-bound anti-CD3 (4 g/ml). After 4 h, Th17 
cells were labeled with 75 l of previously crosslinked (Controlled Protein-Protein 
Crosslinking Kit; Pierce) anti-CD45 (clone 30-F11; BD Pharmingen) and anti-IL-
17 (clone Tc11-18H10; BD Pharmingen) Abs (0.2 mg/ml) for 5 min on ice. 
Labeled cells were then diluted in prewarmed complete RPMI 1640 to a 
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concentration of 105 cells/ml and rotated for 1 h at 37°C. After capture, the Th17 
cells were stained with 100 l of biotin-labeled anti-IL-17 (0.2 mg/ml; clone Tc11-
8H4.1; BD Pharmingen) for 15 min before washing and incubating 10 min with 
Streptavidin-PE (BD Pharmingen). IL-17 captured cells were sorted using a 
FACS Aria cell sorter (BD Biosciences).  
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RESULTS 
Tc17 cells develop in vitro under similar conditions as Th17 cells 
Naïve CD4 T cells develop into Th17 cells in the presence of TGF and IL-6.  To 
determine if these cytokines also promote IL-17 production from CD8 T cells, we 
activated total CD8 cells in the presence of TGF, IL-6, and IFN- neutralizing 
antibodies for 5 days.  Compared to CD4 cells, CD8 cells cultured in IL-17 
promoting conditions routinely contained higher percentages of IL-17 and IFN- 
expressing cells (Fig 3A).  The percentage of IL-17 expressing cells varied 
between experiments, but consistently peaked by Day 3 of culture, even without 
irradiated APCs, and maintained expression for at least 6 days (Fig 3B).  Similar 
to Th17 cells, both TGF and IL-6 were required for IL-17 production because 
minimal IL-17 populations were produced in the presence of each cytokine alone 
(Fig 3C).  As expected, IL-12 stimulated CD8 T cells to produce high levels of 
IFN-.  In the presence of all three cytokines, a slightly reduced Tc17 population 
developed compared to TGF + IL-6 stimulated cultures.  Meanwhile, the Tc1 
population was greatly reduced compared to cultures stimulated with IL-12 alone 
indicating that Tc17 development is dominant to Tc1 development in this 
situation.  IL-23 is a cytokine known to be critical for maintenance of Th17 cells 
but is unable to differentiate Th17 cells from naïve CD4 T cells.  Similarly, IL-23 
was unable to develop Tc17 cells from total CD8 T cells.  In addition, IFN- 
inhibited Tc17 development because in the absence of IFN- neutralizing 
antibodies, IL-17 production was reduced approximately 2 fold (Fig 3C).  
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Figure 3.  TGF + IL-6 induces Tc17 cells.  (A) Total CD8+ or CD4+ T cells 
were stimulated for 5 days with irradiated APC’s in IL-17 skewing conditions 
(TGF + IL-6 and neutralizing antibodies to IFN- and IL-4).  IL-17+ and IFN-+ 
cells were detected by intracellular cytokine staining.  (B)  Total CD8+ T cells 
were cultured in Tc17 conditions (TGF + IL-6 and anti-IFN-) with or without 
irradiated APC’s.  IL-17+ cells were detected by ICS on various days.  (C)  Total 
CD8 T cells were stimulated for 5 days in the presence of IL-12 or anti-IFN- and 
the indicated cytokines.  IL-17 and IFN- were detected by ICS.  Data are 
representative of at least 2 experiments. 
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Previously, total CD8 T cells, which contain both memory and naïve CD8 T cells, 
were used to develop Tc17 cells.  To test the development of Tc17 cells from a 
naïve population alone, CD8 cells were isolated from OT-I / Rag1-/- mice.  These 
CD8 T cells have a transgenic TCR to Ova257-264 with the amino acid sequence – 
SIINFEKL, and are naïve with a CD44loCD122lo surface phenotype (Fig 4A).  
Again, Tc17 development required the combination of TGF and IL-6 and was 
dominant to Tc1 development in OT-I cells stimulated with TGF+IL-6+IL-12 (Fig 
4B).  Unlike total CD8 cells, naïve CD8 T cells stimulated with IL-23 developed a 
small Tc17 population.  This has also been seen with CD8+ T cells from human 
cord blood (Vanden Eijnden et al., 2005), but is somewhat unexpected because 
naïve CD4 cells cannot develop into Th17 cells with IL-23 stimulation.  It is 
possible that naïve CD8 cells already express the IL-23 receptor or upregulate 
the receptor faster than CD4 cells do upon TCR stimulation.  Th17 cell 
development also includes an autocrine feedforward step where IL-21 is 
produced and can replace IL-6 to induce Th17 cells in the presence of TGF 
(Wei et al., 2007).  Likewise, TGF+IL-21 induce a significant population of Tc17 
cells that was dependent on the presence of both cytokines (Fig 4B).      
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Figure 4.  OT-I / Rag1-/- CD8 T cells have similar cytokine requirements for 
Tc17 developoment as total CD8 T cells.  (A)  Isolated splenic CD8+ T cells 
from OT-I / Rag1-/- and C57BL/6 mice were stained for surface expression of 
CD44, CD122, and CD62L.  (B)  OT-I / Rag1-/- CD8 T cells were stimulated for 5 
days in the presence of IL-12 or -IFN- and the indicated cytokines after which 
IL-17 and IFN- were detected using ICS.  Data are representative of at least 2 
experiments. 
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Th17 cells are characterized by their ability to secrete IL-17A (IL-17), but also 
produce IL-17F, IL-21, and IL-22 to mediate their functions.  Th17 cells also 
upregulate the IL-23 receptor.  Likewise, Tc17 cells express elevated levels of 
IL17F, IL-21, and IL-22 and upregulate IL23R when compared to Tc1 cells (Fig 
5A, B).   
 
Th17 cytokines are proinflammatory and promote immune responses.   However, 
if TGF is present without IL-6 or other inflammatory cytokines during CD4 T cell 
priming, a regulatory T cell characterized by Foxp3 expression develops to 
suppress immune responses.  When cultured with TGF, CD8 T cells also 
develop a Foxp3-expressing population which is downregulated in the presence 
of IL-6 or IL-21 (Fig 5C).  These experiments illustrate that compared to Th17 
cells, Tc17 cells are induced by the same cytokines and express many of the 
same characteristic cytokines and surface receptors.  
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Figure 5.  Tc17 cells express IL-17F, IL-21, and IL-22 but not Foxp3.  (A)  
Total CD8+ T cells were stimulated in Tc17 or Tc1 conditions.  After 5 days, cells 
were restimulated and RNA expression for the indicated genes was measured by 
real-time PCR.  Cycle number is normalized to 2-microglobulin expression and 
results are represented as fold induction relative to Tc1 samples. (B)  5 day 
differentiated Tc17 or Tc1 cells were restimulated and cell free supernatants 
were used to measure IL-22 protein levels by ELISA assay.  (C) Total CD8 T 
cells were stimulated for 5 days in the presence of anti-IFN- and the indicated 
cytokines.  Cells were restimulated and IL-17 and Foxp3 were detected by ICS.  
Data are representative of 2 experiments. 
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Tc17 cells are noncytotoxic   
Compared to other CD8 T cell subsets, Tc17 cells express low levels of IFN-.  
To determine if Tc17 cells also differ functionally from other CD8 T cells in their 
ability to mediate cell death, we performed standard chromium release assays.  
OT-I cells differentiated for 5 days were used as effector cells and EG.7 cells (an 
EL-4 cell line expressing ova) were used as the specific target.  Tc17 populations 
were unable to lyse the target cells even at the highest effector to target ratio 
while Tc1 cells showed increased killing with the addition of increasing amounts 
of effector cells (Fig 6A).  Tc17 cells also remained noncytotoxic with the addition 
of ConA to increase their stimulation (Fig 6B).  Since Tc17 cells were 
noncytotoxic, we wanted to determine if they had a regulatory function and could 
inhibit Tc1 mediated lysis.  Increasing amounts of Tc17 cells were added to a 
ratio of Tc1 cells which lysed ~60% of the target cells.  Typically, regulatory T 
cells can suppress proliferation in vitro when they are in similar numbers as the 
target cells.  However, Tc17 cells were only able to compete and lower Tc1 
mediated lysis when the Tc17 cells were at a 10 fold excess to the Tc1 cells (Fig 
6C).   Therefore, in addition to being noncytotoxic, Tc17 cells do not actively 
inhibit Tc1 mediated killing.   
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Figure 6.  Tc17 cells are non-cytotoxic.  (A)  OT-I / Rag1-/- CD8+ T cells were 
stimulated in Tc17 or Tc1 conditions to generate effector cells.  After 5 days, (left 
panel) effectors were added at increasing ratios to EG.7 target cells labeled with 
Cr51.   The killing assay was incubated for 6 hrs before measuring Cr51 released 
into the supernatant.  (right panel) Nonspecific EL-4 and specific EG.7 target 
cells were labelled with two different concentrations of CFSE and mixed in a 1 to 
1 ratio.  Effector cells were added at increasing ratios to the target cells and 
incubated for 4 hrs.  7-AAD was added into the CTL reaction to identify dead 
cells before analysis by flow cytometry.  Ag specific cytotoxicity was calculated 
by the formula: % lysis = 100 x [1 – (E.G7/EL4)experimental / (E.G7/EL4)control]. (B) 
Cr51 release assays were performed with increasing ratios of Tc17 effectors 
incubated plus (   ) or minus (   ) 2.5 g/ml ConA included in the assay. (C)  Cr51 
release assays were performed with Tc1 cells at a 20 to 1 effector to target cell 
ratio.  Increasing numbers of Tc17 (    ) or naïve (    ) CD8 T cells were included 
with the Tc1 cells before measuring Cr51 release.  Data are representative of at 
least 2 experiments. 
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Cytotoxic CD8 T cells induce apoptosis in target cells by secreting effector 
molecules, such as perforin and granzyme B, and through Fas-FasL interactions.  
To determine if the noncytotoxic phenotype seen in Tc17 populations was 
associated with low expression of these effector molecules, we differentiated 
CD8 T cells in Tc17 and Tc1 conditions for 5 days.  Compared to Tc1 cells, Tc17 
cells expressed low levels of Perf, Gzmb, and Fasl consistent with their 
noncytotoxic function (Fig 7A).  TNF has also been reported to contribute to 
cytotoxicity in some instances (Qin et al., 2004; Zhang et al., 2008; Chavez-
Galan et al., 2009) and is expressed at high levels in both Tc17 and Tc1 cells 
(Fig 7B).   However, the previous chromium release assay illustrated that high 
TNF expression from Tc17 cells was insufficient to induce cell mediated 
cytotoxicity.   
 
To determine if low expression of cytotoxic molecules was specific to cells 
cultured in Tc17 inducing conditions or a result of stimulation from TGF alone, 
we measured granzyme B expression in cell populations cultured with various 
cytokines for 5 days.  Low percentages of granzyme B expressing cells were 
selectively seen in IL-17 promoting conditions, while CD8 T cells cultured with 
individual cytokines alone had high percentages of granzyme B expressing cells 
(Fig 7C).  This suggested that Tc17 inducing conditions downregulated granzyme 
B expression. We were unable to detect perforin and Fas Ligand by intracellular 
or cell surface staining, therefore, granzyme B was used as a representative 
cytotoxic molecule in future experiments.     
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Figure 7.  Tc17 cells have low expression of Perf, Gzmb, and Fasl.  (A)  Total 
CD8+ T cells were stimulated in Tc17 or Tc1 conditions.  After 5 days, cells were 
restimulated and RNA expression for the indicated genes was measured using 
real-time PCR.  Cycle number is normalized to 2-microglobulin expression and 
results are represented as fold induction relative to Tc17 samples. (B) 5 day 
differentiated Tc17 and Tc1 cells were restimulated and TNF, IL-17, and IFN- 
were detected using ICS. (C) Total CD8 T cells were stimulated for 5 days in the 
presence of IL-12 or anti-IFN- and the indicated cytokines.  Cells were 
restimulated and Granzyme B and IL-17 were detected using ICS.  Data are 
representative of 2 experiments. 
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Expression of Th17 and Tc1 transcription factors in Tc17 cells  
RORt is both necessary and sufficient for Th17 development.  Meanwhile T-bet 
and Eomes are each critical for optimal expression of IFN- and cytotoxic 
molecules in CD8 T cells.  To begin to understand the molecular mechanisms 
regulating Tc17 cells, we analyzed transcription factor expression in cells 
activated for 5 days in the presence of Tc17 and Tc1 skewing cytokines alone or 
in various combinations.  Rorc was selectively induced in cells cultured under 
Tc17 conditions and was undetectable or had low expression in the presence of 
individual cytokines (Fig 8).  Induction of Tbx21 was highest in Tc1 cells, while 
TGF+IL6- and TGF+IL21-induced Tc17 cells had selectively low Tbx21 
expression with ~2 fold less Tbx21 expression than cells stimulated with TGF 
alone.  IL-12 added to TGF+IL6 conditions was only able to partially recover 
Tbx21 expression compared to IL-12 alone.  Conditions inducing IL-17 
expression also had selectively low levels of Eomes compared to incubation with 
single cytokines alone.  Runx3 is another protein shown to be critical for Tc1 
development; however there was no significant difference in Runx3 expression 
between Tc17 cells and Tc1 cells (Fig 8).  Therefore, induction of IL-17 and 
repression of IFN- and granzyme B in Tc17 cells correlates with high Rorc 
expression and low Tbx21 and Eomes mRNA levels.   
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Figure 8.  Tc17 cells express Rorc and inhibit Tbx21 and Eomes.  Total 
CD8+ T cells were stimulated in the presence of IL-12 or anti-IFN- and the 
indicated cytokines.  After 5 days, RNA expression for the indicated genes was 
measured by real-time PCR.  Cycle number is normalized to 2-microglobulin 
expression.  Results are represented as fold induction relative to TGF+IL-6 
cultured samples and presented as mean ± SD of duplicate sample. Data are 
representative of 2 experiments. 
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CD8 T cells secrete IFN- upon stimulation through the TCR.  Even though IFN- 
was neutralized in the previous figure, we also utilized IFN- deficient CD8 T cells 
in experiments side-by-side with those in Fig 8 to eliminate the possibility of 
autocrine IFN- effects on the regulation of these transcription factors.  Similar to 
the results in the previous figure, conditions which induce IL-17 selectively 
upregulate Rorc and downregulate Tbx21 and Eomes (Fig 9).   
 
IFN- was previously shown to inhibit Tc17 development.  Consistent with this, 
Ifng-/- Tc17 cells have higher expression of Rorc (top panel of Fig 9 vs top panel 
of Fig 8).  
 
In CD4 T cells, T-bet can be induced through IFN-  Stat1 signals.  Tc17 cells 
secrete lower levels of IFN- than cells stimulated with TGF or IL-6 alone.  Low 
Tbx21 expression in Tc17 cells is not an indirect result of lower IFN- expression 
because Tc17 cells lacking IFN- still express lower levels of Tbx21 than Ifng-/- 
cells stimulated with TGF or IL-6 alone. 
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Figure 9.  IFN- inhibits Rorc and is not necessary for Tbx21 or Eomes 
expression.  Ifng-/- CD8+ T cells were stimulated in the presence of IL-12 or anti-
IFN- and the indicated cytokines.  After 5 days, RNA expression for the 
indicated genes was measured by real-time PCR.  Cycle number is normalized to 
2-microglobulin expression.  Results are represented as fold induction relative to 
WT TGF+IL-6 cultured samples from Fig 8 and presented as mean ± SD of 
duplicate samples. Data are representative of 2 experiments. 
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To better understand transcriptional regulation of Tc17 cells, the temporal 
regulation of Rorc, Tbx21, and Eomes were examined in developing Tc17 cells.  
The expression of Rorc in Tc17 cells peaked at Day 3 of culture before 
decreasing (Fig 10A, B), although IL-17 expression was stable from Day 3 to Day 
6 of development (Fig 3B).  T-bet expression in Tc17 cells decreased during the 
5 day culture to levels significantly below Tc1 cells after an approximately 4 fold 
induction of T-bet on Day 1 (Fig 10A).  Previous reports have shown that Eomes 
is induced upon TCR stimulation and inhibited by IL-12.  Consistent with this, the 
highest amount of Eomes protein was detected in neutralizing conditions, with 
Tc17 populations inhibiting Eomes even more than Tc1 populations (Fig 10B).  
Tc17 cells therefore transiently upregulate a Th17 master regulator and 
downregulate Tc1 transcription factors during their transition into IL-17 secreting 
T cells.   
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Figure 10.  Temporal regulation of Tbx21, Eomes, and Rorc in Tc17 cells.    
(A) CD8+ T cells were stimulated in Tc17 or Tc1 conditions and separated from 
the APCs in culture using histopaque on the indicated days.  RNA was isolated 
and gene expression was analyzed by qPCR and normalized to 2-microglobulin 
expression.  Data represent fold induction relative to Day 1 Tc17 cells and 
presented as mean ± SD of duplicate samples.  (B) Protein expression in Tc17 
and Tc1 populations was measured using ICS.  Histograms are displayed as the 
indicated sample (red histogram) with the percent positive based on an overlaid 
control (dark black line).  Tc1 cells (Day 5) were overlaid for a Rort negative 
control, Tbx21-/- Tc17 cells (Day 5) were overlaid for a T-bet negative control, and 
unstained cells (Day 5) were overlaid for an Eomes negative control.  Data are 
representative of at least 2 experiments. 
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Role of Stat Proteins and T-bet in CD8 T cell subset development 
 
In CD4 T cells, Stat proteins are well established as upstream to master 
regulators of lineage development.  IL-6  Stat3  RORt signals are critical for 
Th17 development, while IFN-  Stat1  T-bet and IL-12  Stat4 signals are 
important for Th1 development.  The Th1 factors Stat1 and T-bet also inhibit 
Th17 formation.  Meanwhile, the role of Stat proteins in CD8 T cells is not as 
clear, although in most instances, it appears that IL-12  Stat4 signals are 
necessary for optimal IFN- production while IFN-  Stat1 signals are 
dispensable.    
 
To determine the regulation of Tc17 cells by Stat proteins and important CD4 
lineage transcription factors, we utilized various Stat deficient and also T-bet 
deficient CD8 T cells and analyzed their ability to produce IL-17 in 5 day in vitro 
cultures activated in Tc17 skewing conditions.   
 
In the absence of Stat3 almost no Tc17 cells developed and instead, there was a 
larger percentage of IFN- secreting cells.  Meanwhile, Stat4 was not required 
and did not inhibit Tc17 development.  In the absence of either T-bet or Stat1, an 
increased percentage of Tc17 cells was observed (Fig 11A).  The requirement of 
Stat3 in Tc17 development and Tc17 inhibition by T-bet and Stat1 was also 
observed when protein levels were analyzed using ELISA assays (Fig 11B).   
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5 day differentiated Tc1 cells secrete high levels of IFN- and were used to better 
understand Stat protein regulation of IFN- production in our system.  In the 
absence of T-bet, Tc1 development was impaired and the percentage of IFN- 
secreting cells was decreased even more in the absence of Stat4.  Tc1 cells 
developed normally in the absence of Stat1 (Fig 11A, B).   
 
These data suggest that Stat protein and T-bet regulation of Tc17 cells is similar 
to their regulation of Th17 cells.  Meanwhile, in our system, optimal Tc1 
development requires Stat4 and T-bet.   
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Figure 11.  Stat protein regulation of Tc17 and Tc1 development.  (A) Total 
CD8+ T cells from Stat3CD4-/-, Stat4-/-, Tbx21-/-, Stat1-/- and strain matched wild 
type mice were stimulated in Tc17 or Tc1 conditions for 5 days.  IL-17 and IFN- 
were detected by ICS.  (B)  Five day differentiated Tc17 or Tc1 cells were 
restimulated and cell free supernatants were used to measure IL-17 and IFN- 
protein levels by ELISA assay.  Typical cytokine amounts are shown on the left 
side of the panel and ELISA fold induction relative to wild type samples are 
shown on the right.  Data are representative of at least 2 experiments. 
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Role of Stat3 and RORt in Tc17 development 
 
To further analyze positive and negative regulation of the Tc17 program, we 
determined the effect of Stat protein deficiency on the production of additional 
Tc17 cytokines, surface receptors, and transcription factors.   
 
In CD4 T cells, Stat3 is required not only for IL-17 expression, but also for 
additional proteins associated with the Th17 phenotype.  To determine if Stat3 is 
required for multiple aspects of the Tc17 phenotype, expression of Rorc, Il23r, 
and Il21 was determined by real-time PCR and found to be greatly reduced in 
Stat3CD4-/- Tc17 cells (Fig 12A).  In addition, Stat3CD4-/- Tc17 cells expressed 
higher levels of the Tc1 transcription factors T-bet and Eomes (Fig 12B), 
consistent with the partial Tc1 phenotype seen in Fig 11A.  Perf, Gzmb, and Fasl 
expression were also increased ~2, 8, and 7 fold respectively in Stat3 deficient 
Tc17 cells (Fig 12C).  Therefore, in Tc17 cells, Stat3 is critical for multiple 
aspects of the IL-17 program and at the same time inhibits Tc1 transcription 
factors and cytotoxic gene expression.   
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Figure 12.  Stat3 is required for the Tc17 program and inhibits Tc1 genes.  
(A,B,C) WT or Stat3CD4-/- CD8+ T cells were stimulated in Tc17 or Tc1 conditions.  
After 5 days, RNA expression for the indicated genes was measured by real-time 
PCR.  Expression of transcription factors were analyzed from unstimulated 
samples and expression of cytokines, cytokine receptors, and cytotoxic 
molecules were analyzed from stimulated samples.  Cycle number is normalized 
to 2-microglobulin expression and results are represented as fold induction 
relative to WT Tc17 samples.  Data are representative of 2 experiments. 
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Since Stat3 is necessary for the development of IL-17-secreting CD8 T cells, we 
wanted to assess the ability of Stat3 to promote IL-17 development in a condition 
which does not normally promote Tc17 development.  To test this, WT CD8 T 
cells differentiated in Tc1 conditions were transduced with a bicistronic retrovirus 
containing a H-2Kk selectable marker and either no insert or expressing a 
constitutively active Stat3 (Stat3C).  After 5 days, H-2Kk positive cells were 
purified by FACS sorting and cytokine expression was analyzed using ELISA and 
ICS.  Expression of Stat3C in Tc1 cells increased IL-17 production and inhibited 
IFN- secretion (Fig 13 A, B) suggesting that Stat3 can promote the development 
of IL-17 secretion even in Tc1 conditions.   
 
The increase of granzyme B in Stat3 deficient Tc17 cells (Fig 12C) suggested the 
possibility that Stat3 could inhibit granzyme B.  To determine if Stat3 
overexpression could reduce granzyme B levels, differentiating Tc1 cells were 
transduced with a bicistronic retrovirus containing a H-2Kk selectable marker and 
either no insert or Stat3C.  After 5 days, Stat3C transduced Tc1 cells maintained 
high levels of granzyme B (Fig 13C).  Thus, Stat3 may inhibit granzyme B 
production in Tc17 cells, but does not appear to do so in Tc1 cells.    
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Figure 13.  Stat3C increases IL-17 production and inhibits IFN- but not 
granzyme B.  CD8+ T cells were stimulated in Tc1 or Tc17 conditions.  After 1 
day of culture, cells were transduced with an MSCV control or Stat3C-expressing 
retrovirus as indicated.  Cells were analyzed after an additional 4 days of culture.  
(A)  H-2Kk positive cells were purified by FACs sorting and restimulated with anti-
CD3 for 24 hrs.  Cell free supernatants were used to measure IL-17 and IFN- 
protein levels by ELISA.  (B, C) IFN-, Granzyme B and IL-17 were detected 
using ICS.  Plots are gated on live H-2Kk+ cells.  Data are representative of 2 
experiments. 
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Stat3 induces several proteins including RORt.  Therefore, we wanted to assess 
the ability of RORt alone to promote IL-17 development.  To test this, WT CD8 T 
cells differentiated in Tc1 conditions were transduced with a bicistronic retrovirus 
containing a GFP selectable marker and either no insert or an insert coding for 
RORt.  After 5 days, GFP positive cells were purified by FACS sorting and 
restimulated for ELISA analysis or analyzed using ICS and gated on the GFP+ 
population.  Expression of RORt in Tc1 cells increased IL-17 production to 
almost half the amount seen in Tc17 cells using ELISA, although this increase 
was less dramatic when analyzed by ICS (Fig 14 A, B).  Unexpectedly, RORt 
also increased IFN- measured by ELISA although not by ICS (Fig 14 A, B) 
suggesting that RORt can promote IL-17 and IFN- secretion.   
 
While Stat3 overexpression did not inhibit granzyme B production in Tc1 cells, 
we also wanted to determine if RORt overexpression alone could affect 
granzyme B production.  Differentiating Tc1 cells were transduced with RORt, 
and after 5 days, RORt transduced cells were found to have approximately 20% 
less Granzyme B as control transduced cells (Fig 14C).  Thus, even though 
Stat3C does not appear to inhibit granzyme B in Tc1 cells, RORt overexpression 
shows slight granzyme B reduction.    
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Figure 14.  RORt increases IL-17 and IFN- production and inhibits 
granzyme B.  CD8+ T cells were stimulated in Tc1 or Tc17 conditions.  After 1 
day of culture, cells were transduced with MIEG control or RORt-expressing 
retroviruses.  Cells were analyzed after an additional 4 days of culture.  (A)  GFP 
positive cells were purified by FACs sorting and restimulated with anti-CD3 for 24 
hrs.  Cell free supernatants were used to measure IL-17 and IFN- protein levels 
by ELISA.  (B, C) IFN-, Granzyme B and IL-17 were detected using ICS.  Plots 
are gated on live GFP+ cells.  Data are representative of 2 experiments. 
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To confirm the granzyme B reduction seen upon RORt transduction, we also 
analyzed Gzmb RNA.  Tc1 cells overexpressing RORt contained an 
approximately 2 fold reduction in Gzmb RNA compared to control transduced 
cells, although inhibition of cytotoxic genes seemed to be Gzmb specific as Perf 
and Fasl were not reduced with RORt overexpression (Fig 15A).   
 
To determine if increased IFN- in RORt transduced cells could be due to 
changes in Tc1 transcription factors, Tbx21 and Eomes expression was also 
analyzed.  Tbx21 is increased 2-3 fold higher in transduced cells while there was 
no significant change in Eomes expression (Fig 15B).  Therefore, the increased 
IFN- seen with RORt overexpression correlates with increased Tbx21 
expression.   
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Figure 15.  Effects of RORt overexpression on cytotoxicity genes and Tc1 
transcription factors.  (A, B) Total WT CD8+ T cells were stimulated in Tc1 
conditions.  After 1 day of culture, cells were transduced with either a MIEG 
control or RORt-expressing retrovirus.  Cells were analyzed after an additional 4 
days of culture.  RNA expression for the indicated genes was measured by real-
time PCR.  Expression of cytotoxic molecules was analyzed from stimulated 
samples and expression of transcription factors were analyzed from unstimulated 
samples.  Cycle number is normalized to 2-microglobulin expression and results 
for all samples except Rorc are represented as fold induction relative to MIEG 
transduced Tc1 samples.  Rorc expression is represented as fold induction 
relative to RORt transduced Tc1 cells.  Data are representative of 2 
experiments. 
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Previously, we found that Tc17 cells produced much less granzyme B than CD8 
T cells stimulated in the presence of individual cytokines alone (Fig 7C).  Since 
RORt was able to slightly reduce granzyme B in Tc1 polarizing conditions, we 
wanted to assess the ability of RORt to affect cytokine production in CD8 T cells 
in the absence of differentiating signals.   
 
First, to determine the cytokine production of cells stimulated in the absence of 
exogenous cytokines, we activated CD8 cells for 5 days in the presence of IFN- 
neutralizing antibodies and compared to CD8 cells stimulated in Tc1 and Tc17 
inducing conditions.  After 5 days of culture in the presence of IFN- neutralizing 
antibodies, 55% of CD8 T cells were positive for IFN-.  The percentage of IFN- 
producing cells was increased to 92% in Tc1 conditions and reduced to 13% in 
Tc17 conditions (Fig 16A, top panel).  Almost all cells (89%) were positive for 
granzyme B upon activation alone and similar to IFN- expression, granzyme B 
expressing cells were decreased in Tc17 conditions (Fig 16A, middle panel).  To 
ensure that IFN- was being neutralized and did not have an autocrine effect to 
induce granzyme B expression, Ifng-/- CD8 T cells were stimulated in the 
absence of exogenous cytokines and also found to develop a high percentage of 
granzyme B expressing cells(Fig 16A, bottom panel).   
 
Next we analyzed expression of Tc1 transcription factors.  Eomes expression 
was highest in neutralizing conditions during a 5 day culture and was inhibited 
with the addition of IL-12 as previously reported (Takemoto et al., 2006), while 
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Tc17 conditions further reduced Eomes.  T-bet expression was induced in the 
presence of IL-12 and inhibited in IL-17 promoting conditions (Fig 16B).  
Previously, we observed that IFN- did not induce Eomes or T-bet in multiple 
conditions (Figs 8 and 9).  Similarly, IFN- was not necessary for Eomes or T-bet 
expression in CD8 T cells stimulated in the absence of differentiating signals (Fig 
16B).  Therefore CD8 T cells stimulated through the TCR alone for 5 days induce 
Eomes and express T-bet to produce IFN- and high levels of granzyme B. 
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Figure 16.  TCR stimulation induces IFN- and granzyme B.  (A) CD8+ T cells 
were stimulated for 5 days with irradiated APC’s and -IFN- or in Tc1 or Tc17 
skewing conditions.  IL-17+, IFN-+, and granzyme B+ cells were detected by 
intracellular cytokine staining.  (B)  RNA expression for the indicated genes was 
measured by real-time PCR from unstimulated samples.  Cycle number is 
normalized to 2-microglobulin expression and results are represented as fold 
induction relative to samples incubated with TGF+IL6. Data are representative 
of at least 2 experiments. 
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Next, we wanted to assess the ability of RORt to inhibit granzyme B production 
in the absence of exogenous cytokines.  CD8 T cells were differentiated in the 
presence of neutralizing IFN- antibodies and transduced with a bicistronic 
retrovirus containing a GFP selectable marker and either no insert or expressing 
RORt.  After 5 days, GFP positive cells were analyzed using ICS and gated on 
the GFP+ population.  Expression of RORt slightly decreased granzyme B 
expression (78% to 69%) (Fig 17A), similar to Fig 14C where RORt was 
overexpressed in Tc1 cells.  In Fig 7, we found that stimulation in the presence of 
TGF alone was able to slightly reduce granzyme B (96% down to 71%).  To 
explore the possibility that TGF and RORt synergize to reduce granzyme B in 
Tc17 cells, we transduced WT CD8 T cells stimulated in the presence of TGF 
with an RORt expressing retrovirus.  Again, RORt slightly reduced granzyme B 
expression, but did not inhibit granzyme B to levels seen in Tc17 cells (Fig 17B).  
It is not known why control transduction of CD8 T cells differentiated in Tc17 
conditions often contained lower percentages of IL-17 expressing cells than 
normally seen in untransduced Tc17 populations.   
 
RORt transduction into cells stimulated in neutralizing conditions or with TGF 
slightly increased the percentage of IFN- expressing cells consistent with the 
effects seen when RORt was transduced into Tc1 cells (Fig 17B).   
 
RORt overexpression is therefore only partially responsible for the inhibition of 
granzyme B in Tc17 cells.   
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Figure 17.  RORt overexpression reduces granzyme B.  (A, B) CD8+ T cells 
were stimulated in the presence of -IFN-, TGF + -IFN-, or TGF + IL-6 + -
IFN- (Tc17).  After 1 day of culture, cells were transduced with MIEG control or 
RORt-expressing retroviruses.  Cells were analyzed after an additional 4 days of 
culture.  IFN-, Granzyme B and IL-17 were detected using ICS.  Plots are gated 
on live GFP+ cells.  Data are representative of 2 experiments. 
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Role of Stat1 and T-bet in Tc17 development 
 
To determine if Stat1 inhibits other Tc17 transcription factors and cytokines in 
addition to IL-17, we analyzed expression of Rorc, Il17f, Il21, and Il22 in Stat1-/- 
Tc17 populations.  Similar to IL-17, these Tc17 molecules were upregulated in 
Stat1-/- Tc17 cells suggesting that Stat1 inhibits several aspects of the Tc17 
program (Fig 18A).  Stat1 deficiency decreased Tbx21 expression consistent with 
previous studies which have shown that Stat1, along with Stat4, are upstream 
regulators of T-bet in CD8 cells (Morishima et al., 2005; Yang et al., 2007b).  
Stat1 deficiency had little effect on Eomes expression in Tc17 populations (Fig 
18B).   
 
To determine if T-bet also inhibited the Tc17 program, expression of Tc17 factors 
were analyzed in Tbx21-/- Tc17 cells.  Similar to Stat1-/- Tc17 cells, Rorc, Il17f, 
and Il21 were all upregulated in Tbx21-/- Tc17 (Fig 18C).  It was not determined if 
Stat1 mediated its inhibitory effects in Tc17 cells by inducing T-bet and it would 
have been interesting to see if ectopic T-bet expression in Stat1-/- Tc17 cells 
could reduce IL-17 and other Tc17 factors to wild type Tc17 levels.  
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Figure 18.  Both Stat1 and T-bet inhibit the Tc17 program.  (A,B) WT or  
Stat1-/- CD8+ T cells were stimulated in Tc17 or Tc1 conditions.  After 5 days, 
RNA expression for the indicated genes was measured by real-time PCR.  
Expression of transcription factors were analyzed from unstimulated samples and 
expression of cytokines were analyzed from stimulated samples.  Cycle number 
is normalized to 2-microglobulin expression and results are represented as fold 
induction relative to WT Tc17 samples.  (C,D)  WT or Tbx21-/- CD8+ T cells were 
stimulated and analyzed as in parts A and B.  Data are representative of 2 
experiments. 
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Role of Stat4 and T-bet in Tc1 development 
 
In our system, we found that optimal Tc1 development was dependent on Stat4 
and T-bet.  To determine if Stat4 could be regulating Tc1 development through T-
bet or another Tc1 transcription factor, Eomes, we analyzed expression of these 
factors in 5 day in vitro differentiated Tc1 cells deficient in Stat4.  Stat4-/- Tc1 cells 
had similar Tbx21 RNA expression as wild type Tc1 cells and slightly decreased 
T-bet protein (71% vs. 88%) (Fig 19A).  Meanwhile, Eomes expression was 
increased in Stat4-/- Tc1 cells, although apparently not enough to overcome a 
decrease in IFN- production.  To determine if Stat4 regulated cytotoxicity genes 
in addition to IFN- in Tc1 cells, RNA levels of Perf, Gzmb, and Fasl were also 
measured.  Stat4-/- Tc1 cells had decreased levels of all three genes even though 
they were still expressed higher than in WT Tc17 cells (Fig 19B).  Granzyme B 
protein was also analyzed by ICS and similar to the RNA data had decreased 
levels in Stat4-/- Tc1 cells (Fig 19C).  Therefore, Stat4 is a positive regulator of 
IFN- and cytotoxicity genes in IL-12 induced Tc1 cells.  Since Eomes is not 
decreased in Stat4-/- cells, Stat4 regulation of these genes is Eomes 
independent.  However, decreased T-bet protein levels in Stat4-/- Tc1 cells 
suggest that Stat4 may partially regulate IFN- and cytotoxicity genes through T-
bet stabilization. 
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Figure 19.  Stat4 is required for optimal expression of cytotoxic genes in 
Tc1 cells.  (A,B,C) WT or Stat4-/- CD8+ T cells were stimulated for 5 days with 
irradiated APC’s in Tc1 or Tc17 skewing conditions.  RNA expression for the 
indicated genes was measured using real-time PCR with the cycle number 
normalized to 2-microglobulin expression.  Results are represented as fold 
induction relative to WT Tc1 samples for transcription factors and relative to WT 
Tc17 samples for cytotoxic genes.  Intracellular staining was used to detect IFN- 
and granzyme B from stimulated cells and T-bet from unstimulated cells.  Data 
are representative of at least 2 experiments. 
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To determine if T-bet could be regulating Tc1 development through Eomes, we 
analyzed Eomes expression in 5 day in vitro differentiated Tc1 cells deficient in 
T-bet.  Tbx21-/- Tc1 cells had similar Eomes RNA expression as wild type Tc1 
cells (Fig 20A) therefore T-bet did not seem to be mediating its effects through 
Eomes induction.  We also wanted to see if T-bet regulated cytotoxicity genes in 
addition to IFN- in Tc1 cells.  To do this, RNA levels of Perf, Gzmb, and Fasl 
were measured.  Tbx21-/- Tc1 cells had decreased levels of Perf and similar 
levels of Gzmb and Fasl compared to WT Tc1 cells (Fig 20B).  Granzyme B 
protein was also analyzed by ICS and granzyme B expressing cells decreased 
from 94% to 84% in Tc1 cells deficient in T-bet (Fig 20C).  Therefore, T-bet is 
important for optimal IFN-, Perf and Gzmb expression in Tc1 cells, but not for 
Fasl expression.  Since the defects seen in Tbx21-/- compared to Stat4-/- Tc1 cells 
were lesser in magnitude for some genes (Ifng, Perf, Gzmb) and absent in 
another gene analyzed (Fasl), Stat4 most likely has some functions which are 
independent of T-bet as well as possible functions dependent on T-bet.  
 
 77 
0
20
40
60
80
100
WT Tbx21-/-R
el
at
iv
e 
E
om
es
E
xp
re
ss
io
n
0
1
2
3
4
5
WT Tbx21-/-R
el
at
iv
e 
Tb
x2
1
E
xp
re
ss
io
n
Tc1 Tc1
B
C
0
10
20
30
40
WT Tbx21-/- WT
Tc1 Tc17
0
10
20
30
40
WT Tbx21-/- WT
Tc1 Tc17
R
el
at
iv
e 
Fa
sl
E
xp
re
ss
io
n
0
5
10
15
20
WT Tbx21-/- WT
Tc1 Tc17
R
el
at
iv
e 
P
er
fE
xp
re
ss
io
n
R
el
at
iv
e 
G
zm
b
E
xp
re
ss
io
n
A
G
ra
nz
ym
e
B
IFN-
Tc1
WT
89%5%
5%
WT
Tc17
7%6%
8%
Tbx21-/-
71%13%
9%
94% 84% 13%
94% 80% 15%
R
el
at
iv
e 
E
om
es
E
xp
re
ss
io
n
R
el
at
iv
e 
Tb
x2
1
E
xp
re
ss
io
n
R
el
at
iv
e 
Fa
sl
E
xp
re
ss
io
n
R
el
at
iv
e 
P
er
fE
xp
re
ss
io
n
R
el
at
iv
e 
P
er
fE
xp
re
ss
io
n
R
el
at
iv
e 
G
zm
b
E
xp
re
ss
io
n
G
ra
nz
ym
e
B
 
Figure 20.  T-bet is required for optimal expression of Perforin and 
granzyme B in Tc1 cells.  (A,B,C) WT or Tbx21-/- CD8+ T cells were stimulated 
for 5 days with irradiated APC’s in Tc1 or Tc17 skewing conditions.  RNA 
expression for the indicated genes was measured using real-time PCR with the 
cycle number normalized to 2-microglobulin expression.  Results are 
represented as fold induction relative to WT Tc17 samples.  Intracellular staining 
was used to detect IFN- and granzyme B.  Data are representative of at least 2 
experiments. 
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Tc17 cells have low expression of T-bet, IFN-, and granzyme B.  Since T-bet 
contributes to IFN- and granzyme B expression in Tc1 cells, we wanted to 
determine if IL-12 could induce T-bet in Tc17 cells and subsequently induce IFN-
 and granzyme B expression.  WT CD8 T cells were stimulated for 5 days in 
Tc17 conditions and increasing doses of IL-12 after which T-bet and Eomes RNA 
levels were determined and IFN-, granzyme B, and IL-17 expression were 
measured using ICS.  Our standard dose of IL-12 used in Tc1 conditions (5 
ng/ml) increased Tbx21 expression in Tc17 cells approximately 3 fold; however, 
increasing the IL-12 dose did not further increase Tbx21 induction.  IL-12 also did 
not increase Eomes expression in Tc17 cells (Fig 21A).  All doses of IL-12 
partially increased IFN- and granzyme B, which correlated with the Tbx21 
induction, and did not significantly decrease IL-17 (Fig 21B).   
 
TGF is known to downregulate Il12Rb2 in CD4 cells (Gorham et al., 1998) and 
one explanation for the lack of an IL-12 dose response in Tc17 cells is that IL-12 
signaling is diminished in these cells.  To explore this possibility, Stat4 
phosphorylation was examined and found to be decreased in Tc17 cells 
restimulated with IL-12 (Fig 21C).  Decreased IL-12 responsiveness, therefore, is 
likely one reason why increasing IL-12 doses cannot recover Tbx21, IFN- or 
granzyme B in Tc17 cells.  
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Figure 21.  Tc17 cells have reduced IL-12 responsiveness.  (A,B) CD8+ T 
cells were stimulated in Tc17 conditions with increasing doses of IL-12 or in Tc1 
conditions for five days.  RNA expression was measured using real-time PCR 
with the cycle number normalized to 2-microglobulin expression.  Results are 
represented as fold induction relative to Tc17 cells plus 0 ng/ml IL-12.  IFN-, 
Granzyme B and IL-17 were detected using ICS with the results from the dot 
plots summarized in a bar graph.  (C) Five day differentiated Tc1 or Tc17 cells 
were left unstimulated or stimulated with 5 ng/ml IL-12 for 30 minutes before 
staining for phosphorylated Stat4.  Data are representative of 2 experiments. 
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To circumvent the low IL-12 responsiveness and study the role of T-bet in Tc17 
cells, T-bet overexpression experiments were performed.  WT CD8 T cells 
differentiated in Tc17 conditions were transduced with a bicistronic retrovirus 
containing a GFP selectable marker and either no insert or expressing T-bet.  
After 5 days, GFP positive cells were analyzed using ICS.  Expression of T-bet in 
developing Tc17 populations led to a minimal increase in the percentage of IFN- 
secreting cells and inhibited the percentage of IL-17 secreting cells (Fig 22A).  To 
determine if IFN- could be upregulated in Tc17 cells by Eomes overexpression, 
WT CD8 T cells differentiated in Tc17 conditions were transduced with a 
bicistronic retrovirus containing a hCD4 selectable marker and either no insert or 
expressing Eomes.  Eomes transduced cells also led to a minimal increase in the 
percentage of IFN- secreting cells and, unexpectedly, also increased the 
percentage of IL-17 secreting cells.  A report has suggested that T-bet and 
Eomes may function in a synergistic manner (Intlekofer et al., 2008); therefore, 
we wanted to determine if overexpression of T-bet and Eomes together could 
upregulate IFN- in Tc17 cells.  Transduction of both retroviruses did not 
significantly upregulate IFN- in Tc17 cells suggesting that in addition to 
downregulating IL-12 signaling, Tc17 cells are also refractory to Eomes and T-
bet induced IFN- (Fig 22A).  To determine if T-bet or Eomes could increase 
granzyme B in Tc17 cells, differentiating Tc17 cells were transduced with T-bet 
or Eomes or both factors.  After 5 days, either factor alone recovered the 
percentage of granzyme B secreting cells compared to Tc1 populations with 
Eomes having a slightly greater effect than T-bet (Fig 22B).    
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Figure 22.  Effects of T-bet and Eomes overexpression on cytokine 
production from Tc17 cells.  (A, B) CD8+ T cells were stimulated in Tc17 or 
Tc1 conditions.  After 1 day of culture, cells were simultaneously transduced with 
two bicistronic retroviruses – one containing a GFP selectable marker and either 
no insert or expressing T-bet and the other containing a hCD4 selectable marker 
and either no insert or expressing Eomes.  Vector transduced cells were double 
transduced with hCD4 and GFP controls,  Tbet double transductions = 
Tbet+hCD4, Eomes double transduction = Eomes+GFP, and Tbet+Eomes 
equals cells which were transduced with both genes of interest.  Cells were 
analyzed after an additional 4 days of culture.  IFN-, Granzyme B and IL-17 
were detected using ICS.  Plots are gated on live GFP+hCD4+ cells and cytokine 
staining is summarized in bar graphs below the dot plots.  Data are 
representative of 1 experiment. 
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T-bet overexpression was confirmed in Tc17 cells by RNA and consistent with 
Tbx21-/- Tc1 cells (Fig 20A), had no effect on Eomes expression (Fig 23A).  
Likewise, Eomes overexpression had no effect on T-bet RNA levels (Fig 23B).  
We also wanted to determine if overexpression of these transcription factors 
could upregulate other cytotoxic genes in addition to granzyme B.  T-bet 
overexpression increased Perf RNA levels 2.3 fold and Fasl expression 8.4 fold.  
While Eomes expression increased Perf RNA levels 3.1 fold (Fig 23C, D).   
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Figure 23.  Effects of T-bet and Eomes overexpression on transcription 
factors and cytotoxicity genes from Tc17 cells.  (A,C) CD8+ T cells were 
stimulated in Tc17 or Tc1 conditions.   After 1 day of culture, cells were 
transduced with a bicistronic retrovirus containing a GFP selectable marker and 
either no insert or expressing T-bet.  After an additional 4 days of culture, GFP+ 
cells were purified using Facs sorting and RNA expression for the indicated 
genes was measured by real-time PCR.  Cycle number is normalized to 2-
microglobulin expression and results are represented as fold induction relative to 
control transduced Tc17 samples. (B,D)  CD8+ T cells were activated and 
transduced as above with a bicistronic retrovirus containing a hCD4 selectable 
marker and either no insert or expressing Eomes.  Transduced cells were 
analyzed as in parts A and C.  Data are representative of 1 experiment. 
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Role of Stat1 in Tc1 development 
 
Previously we observed decreased Tbx21 RNA in Stat1-/- Tc17 cells (Fig 18B).  
To determine if Tbx21 expression was also decreased in Tc1 cells deficient in 
Stat1, we examined 5 day in vitro differentiated Tc1 cells.  Stat1-/- Tc1 cells 
express normal levels of Tbx21 and increased Eomes (Fig 24A).  In addition, 
similar to the normal IFN- production seen in these cells, there was normal or 
increased expression of the cytotoxicity genes Perf, Gzmb, and Fasl (Fig 24B).  
Therefore, Stat1 is dispensable for normal IL-12 induced Tc1 programming.  
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Figure 24.  Stat1 is dispensable for Tc1 development.  (A,B) WT (129S6) or 
Stat1-/- CD8+ T cells were stimulated in Tc1 or Tc17 skewing conditions.  After 5 
days, RNA expression for the indicated genes was measured by real-time PCR.  
Cycle number is normalized to 2-microglobulin expression and results are 
represented as fold induction relative to WT Tc17 samples.  Data are 
representative of 2 experiments. 
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Summary of the molecular regulation of Tc17 cells 
We propose a model of Tc17 development as depicted in Fig 25.  Upon TCR 
stimulation, induction of Eomes and T-bet promote a cytotoxic T lymphocyte 
phenotype expressing IFN-, granzyme B, and perforin.  IL-12 induction of Stat4 
augments CTL development to secrete even higher levels of IFN-.  Alternatively, 
in the presence of TGF and IL-6, Stat3 and RORt are induced, Eomes and T-
bet are inhibited, and a Tc17 phenotype develops expressing IL-17A, IL-17F, IL-
21, and IL-22 and upregulating the IL-23R.  The Tc17 phenotype is under 
negative regulation by Stat1 and T-bet.  The plasticity of naïve CD8 T cells 
reveals additional complexities of CD8 T cell differentiation and the importance of 
Stat proteins and lineage specific transcription factors in determining CD8 T cell 
fate.   
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Figure 25.  Development of CD8 T cell subsets.  TCR stimulation induces the 
CTL transcription factors Eomes and T-bet.  The fate of the developing CD8 T 
cell can be modified by cytokines in the environment and the transcription factors 
that are activated.  IL-12 activates Stat4 and T-bet to induce Tc1 cells and TGF 
with IL-6 activates Stat3 and RORt to induce Tc17 cells.  These subsets are 
characterized by the cytokines they secrete – Tc1 cells secrete IFN-, granzyme 
B, and perforin while Tc17 cells secrete IL-17A, IL-17F, IL-21, and IL-22.   
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Tc17 Instability 
CD8 T cells can produce high levels of IL-17 which is not completely suppressed 
by IL-12 stimulation or overexpression of T-bet and Eomes in a one week culture.  
However, CD4 cells producing both IL-17 and IFN- are often observed in in vivo 
disease models and several groups, including ours, have shown that Th17 cells 
are unstable upon restimulation in multiple week cultures.   
 
Upregulation of IFN- and granzyme B in Tc17 cells 
 
To determine if Tc17 cells are also unstable, we restimulated five day 
differentiated Tc17 for an additional five days in conditions containing various 
cytokines and neutralizing antibodies – a neutralizing condition (-IFN-), a Tc17 
skewing condition (TGF+IL-6+-IFN-), a Tc1 condition (IL-12), or a combined 
Tc17/Tc1 condition (TGF+IL-6+IL-12+-IFN-) and analyzed cytokine 
production.  Tc17 cells restimulated in a neutralizing condition for a second week 
(Tc17-IFN-) downregulated the percentage of IL-17 secreting cells and 
increased the percentage of IFN- secreting cells (Fig 26A).  This switch from a 
Tc17 population to a Tc1 population was greatly enhanced when the cells were 
restimulated for a second round in the presence of IL-12.  Tc17 populations 
restimulated in Tc17 conditions further increased the percentage of IL-17 
secreting cells while also slightly upregulating the percentage of IFN- secreting 
cells.  In the presence of Tc17 and Tc1 instructive signals together, the 
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percentage of both IFN- and IL-17 secreting cells were upregulated compared to 
one week Tc17 populations (Fig 26A).   
 
To determine the role of IFN- in Tc17 instability, Ifng-/- Tc17 populations were 
restimulated for a 2nd week with the same cytokine / antibody combinations 
described above.  In the absence of IFN-, neutralizing conditions for the 2nd 
week only slightly lowered the percentage of IL-17 secreting cells (Fig 26B) 
suggesting that in the WT Tc17-IFN- condition, IL-17 is reduced via IFN- 
signals.  Ifng-/- Tc17 populations contained more IL-17 secreting cells in each 
respective 2 week condition compared to WT Tc17 cells with a similar trend 
when placed in Tc17, combined Tc17/Tc1, or Tc1 conditions for a second week 
of culture consistent with the inhibitory role of IFN- in a one week culture (Fig 
3C).   
 
CD8 T cells cultured for one week are not always unstable, however, as seen by 
the inability of Tc1Tc17 cells to produce IL-17 (Fig 26C).  Therefore, Tc17 cells 
are uniquely unstable and in a second week of culture produce cytokines which 
are reflective of the instructive cytokines present in the environment – if TGF 
and IL-6 are present, Tc17 polarization is maintained; in the presence of IL-12, 
Tc17 populations switch to a Tc1 population; and if all three cytokines are 
present, both IFN-- and IL-17-secreting cells are developed.   
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Figure 26.  Tc17 cells exhibit plasticity.  (A) WT or (B) Ifng-/- CD8+ T cells 
were stimulated in Tc17 conditions.  After five days, Tc17 cells were restimulated 
in the presence of -IFN- and the indicated cytokines or IL-12 alone for an 
additional five days.  IL-17+ and IFN-+ cells were detected using intracellular 
cytokine staining after the first round of stimulation (Day 5) and also at the end of 
the second round of stimulation (Day 10).  Data are represented as dot plots or 
summarized in bar graphs with 5 day differentiated cells labeled in blue.  (C)  WT 
CD8+ T cells were stimulated in Tc1 (IL-12) conditions and after five days, 
restimulated in Tc17 (TGF + IL-6 + -IFN-) or Tc1 conditions for an additional 
five days.  IL-17+ and IFN-+ cells were detected after the first and second 
rounds of stimulation.  Data are representative of at least 2 experiments. 
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We also wanted to determine if the expression of cytotoxic molecules was 
unstable in Tc17 cells by analyzing granzyme B expression in 2 week cultures.    
One week differentiated Tc17 cells were restimulated for an additional week in 
the presence of the same cytokine and antibody combinations described in the 
previous figure.  Upon restimulation for a second week in neutralizing conditions 
alone, granzyme B is induced from 11% to 84% of the live cell population and 
this increase is enhanced in the presence of IL-12 (Fig 27A).  The TCR mediated 
induction of granzyme B is mostly diminished when TGF and IL-6 are added to 
the IFN- neutralizing antibodies and is not recovered when additionally 
stimulated with IL-12.  The trend in granzyme B instability remained the same 
when IFN- signals were completely removed using Ifng-/- Tc17 cells in a second 
week of culture (Fig 27B).   
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Figure 27.  2 week Tc17 cells upregulate granzyme B.  (A) WT or (B) Ifng-/-
CD8+ T cells were stimulated in Tc17 conditions.  After five days, Tc17 cells 
were restimulated in the presence -IFN- and the indicated cytokines or IL-12 
alone for an additional five days.  IL-17+ and granzyme B+ cells were detected 
using intracellular cytokine staining after the first round of stimulation (Day 5) and 
also at the end of the second round of stimulation (Day 10).  Data are 
represented as dot plots or summarized in bar graphs with 5 day differentiated 
cells labeled in blue.  Data are representative of at least 2 experiments. 
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Next, we analyzed the ability of switched Tc17 cells to mediate cytotoxicity.  One 
week differentiated Tc17 cells from OT-I mice were restimulated for an additional 
week in the presence of neutralizing IFN- antibodies (Tc17-IFN-), in Tc17 
conditions (Tc17Tc17), or in Tc1 conditions (Tc17Tc1) and analyzed in a 
standard chromium release assay.  Tc17-IFN- cells gained cytotoxic ability 
compared to 5 day differentiated Tc17 cells and were able to lyse ~20% of target 
cells at the highest effector to target ratio (30:1) (Fig 28A).  Tc17Tc17 cells 
displayed similar cytotoxic ability and Tc17Tc1 cells had increased cytotoxicity 
although not to the level of Tc1Tc1 cells.  The gain of cytotoxic function 
however did not correlate with granzyme B expression (Fig 28A vs. Fig 27A) – 
Tc17-IFN- and Tc17Tc17 cells had similar cytotoxic potential while 
Tc17-IFN- cells had much higher expression of granzyme B than 
Tc17Tc17 cells, suggesting that optimal cytototoxic function in these cells is 
mediated by many factors.  
 
Cell mediated cytotoxicity was also tested in a CFSE based cytotoxicity assay.  
In this assay, Tc17-IFN- and Tc17Tc17 cells displayed minimal to no 
killing compared to the chromium release assay, while the trends for the cells 
restimulated in Tc1 conditions were similar to the chromium release assay (Fig 
28B).  The slight difference in the results seen in these two assays could be due 
to differences in sensitivity. 
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Figure 28.  IL-12 induces Tc17 cells to become cytotoxic.  OT-I CD8+ T cells 
were stimulated in Tc17 or Tc1 conditions.  After 5 days, cells were restimulated 
in the presence of -IFN-, in Tc17 conditions or in Tc1 conditions for an 
additional five days. (A) Effector cells were added at increasing ratios to ova 
expressing EG.7 target cells labeled with Cr51 and incubated for 6 hrs before 
measuring Cr51 released into the supernatant.  (B)  Nonspecific EL-4 and specific 
EG.7 target cells were labeled with two different concentrations of CFSE and 
mixed in a 1:1 ratio.  Effector cells were added at increasing ratios to the target 
cells and incubated for 4 hrs.  7-AAD was added into the CTL reaction to identify 
dead cells before analysis by flow cytometry.  Ag specific cytotoxicity was 
calculated by the formula: % lysis = 100 x [1 – (E.G7/EL4)experimental / 
(E.G7/EL4)control].  Data are representative of at least 2 experiments. 
 97 
In a one week Tc17 culture, high IL-17 expression and low IFN- and granzyme 
B expression correlate to an induction of Rorc expression and low levels of 
Tbx21 and Eomes expression.  To determine if these transcription factors also 
correlate to cytokine changes seen in switched Tc17 cells, we compared their 
expression levels in one week Tc17 cells to Tc17 cells restimulated in various 
cytokines and antibodies for a second week.  WT Tc17-IFN- cultures 
downregulated Rorc expression and upregulated Tbx21 and Eomes expression 
(Fig 29).  This inhibition of Rorc was mostly absent in IFN- deficient Tc17 cells 
indicating that it was primarily due to TCR induced IFN-.  Tbx21 and Eomes 
expression were also increased in Ifng-/-Tc17-IFN- cultures compared to WT 
Tc17 cells suggesting that IFN- also inhibits Tbx21 and Eomes induction in this 
condition.  When WT Tc17 cells were stimulated in the presence of TGF and IL-
6, Rorc was further induced and Eomes and Tbx21 expression remained low.  
The addition of IL-12 to Tc17 conditions in the second week inhibited Rorc 
induction in WT Tc17 cells, but did not induce Eomes or Tbx21 expression.  
Similar to Tc17-IFN- cultures, Rorc inhibition in Tc17TGF+IL-6+IL-12 
conditions was mostly abrogated in the absence of IFN-, suggesting that 
inhibition is again mediated through IFN-.  WT Tc17Tc1 cells also inhibited 
Rorc and did not induce Tbx21 or Eomes expression (Fig 29).   
 
These trends in Rorc, Tbx21, and Eomes regulation correlate most closely with 
changes in IL-17 and granzyme B, and not with IFN- production suggesting that 
Rorc maintains IL-17 production in a two week culture and Tbx21 and Eomes 
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upregulate granzyme B in the second week.  However, IFN- induced from 2 
week Tc17 cells by IL-12 may be mediated through T-bet and Eomes 
independent pathways.   
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Figure 29.  Five day differentiated Tc17 cells downregulate Rorc and 
upregulate Tbx21 and Eomes when challenged with IL-12.  WT (left panels) 
or Ifng-/- (right panels) CD8+ T cells were stimulated in Tc17 conditions.  After five 
days, Tc17 cells were restimulated in the presence -IFN- and the indicated 
cytokines or IL-12 alone for an additional five days.  RNA expression for the 
indicated genes was measured by real-time PCR after one round of stimulation 
(Day 5) and after two rounds of stimulation (Day 10).  Cycle number is 
normalized to 2-microglobulin expression and results are represented as fold 
induction relative to WT Day 5 Tc17 samples.  Data are representative of 2 
experiments. 
 
 
 100
Role of Stat4 and T-bet in Tc17 instability 
 
Stat4 and T-bet were both previously seen to be important for optimal IFN- 
production from Tc1 cells.  To further study their role in IFN- producing cells and 
begin to understand their importance for IFN- upregulation in Tc17 cells, we first 
analyzed CD8 T cells deficient in both factors together or either factor alone in 
neutralizing conditions or Tc1 conditions for one week.  When stimulated in 
neutralizing conditions, roughly half of the WT CD8 T cells produced IFN- and 
this percentage was reduced 2-3 fold in the absence of T-bet (Fig 30A).  IFN- 
secreting cells were also slightly reduced in the absence of Stat4.  The absence 
of both factors did not further decrease the percentage of IFN--secreting cells 
compared to a deficiency in T-bet alone.   
 
Tc1 conditions increased the percentage of IFN--secreting cells compared to 
neutralizing conditions dependent on Stat4 because this increase was absent in 
Stat4 deficient cells.  IL-12 induced IFN- had a larger decrease with a deficiency 
of both Stat4 and T-bet together compared to a deficiency in either transcription 
factor alone (Fig 30A).  Together, these results suggest that IFN- is induced 
through TCR signals which are partially T-bet dependant and is further enhanced 
upon IL-12 activation of Stat4. 
 
We also wanted to determine the role of T-bet or Stat4 for granzyme B induction.  
WT CD8 T cells stimulated in neutralizing conditions upregulated high levels of 
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granzyme B which was reduced in the absence of Stat4 (89% vs 70%) but not T-
bet (Fig 30B).  Tc1 cells were also dependent on Stat4 for maximal granzyme B 
production.  Unlike in IFN- regulation, double knockout CD8 T cells did not have 
a greater decrease in granzyme B than a single knockout alone for either culture 
condition.   
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Figure 30.  Optimal Tc1 development requires non-redundant Stat4 and T-
bet signals.  (A,B) WT, Tbx21-/-, Stat4-/-, or Tbx21-/- x Stat4-/- CD8+ T cells were 
stimulated for 5 days with -IFN- alone or with IL-12 (Tc1).  IL-17+, IFN-+, and 
granzyme B+ cells were detected by intracellular cytokine staining.  Data are 
representative of 2 experiments. 
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As we analyzed the role of Stat4 and T-bet in IFN- production, we also wanted 
to determine T-bet and Eomes expression levels in the cells from the previous 
figure.  Consistent with a role for T-bet in upregulating IFN- during neutralizing 
conditions, T-bet was induced to high levels in this condition and further induced 
in the presence of IL-12 (Fig 31A).  T-bet expression was not dependent on Stat4 
in neutralizing conditions, but was partially Stat4 dependent in Tc1 conditions.  
Eomes expression meanwhile had the highest expression level in neutralizing 
conditions and was inhibited by IL-12, consistent with previous reports.  In 
neutralizing conditions, Eomes showed partial dependence on both T-bet and 
Stat4 (Fig 31B).   
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Figure 31.  Role of T-bet and/or Stat4 in the expression of CTL transcription 
factors.  WT, Tbx21-/-, Stat4-/-, or Tbx21-/- x Stat4-/- CD8+ T cells were stimulated 
for 5 days in the presence of -IFN- alone or with IL-12 (Tc1).  (A) T-bet and (B) 
Eomes were detected by intracellular cytokine staining.  Data are representative 
of 2 experiments. 
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Previously, we observed that both of these transcription factors were important 
for optimal IFN- production from Tc1 cells, however in two week Tc17 cultures, 
IL-12 induced IFN- without an induction in Tbx21 RNA.  Therefore, we wanted to 
determine the requirements of Stat4 and T-bet in IFN- induction from Tc17Tc1 
cultures using cells deficient in these transcription factors.  WT, Tbx21-/-, Stat4-/-, 
and Tbx21 x Stat4 double knockout CD8 T cells were differentiated into Tc17 
cells.  After 5 days, Tc17 cells were restimulated in a neutralizing condition (-
IFN-) or in a Tc1 inducing condition (IL-12) and cultured for an additional 5 days 
before analysis.  Previously, Tc17 cells stimulated in neutralizing conditions did 
not upregulate IFN- to a significant degree (Fig 26A), and the absence of T-bet 
and/or Stat4 did not affect the basal percentage of cells producing IFN- in 
Tc17-IFN- cultures (data not shown).  However, when Tc17 cells were 
restimulated in the presence of IL-12, the increase of IFN--secreting cells was 
impaired in T-bet deficient Tc17 cells (79% vs. 32%) and was further impaired in 
Stat4 deficient Tc17 cells (79% vs. 7%) (Fig 32A).  Double knockout Tc17 
populations developed almost no cells secreting IFN- when switched in Tc1 
conditions.  The importance of these factors was reversed in regards to IL-17 
inhibition – IL-17 was mostly inhibited in the absence of Stat4, while T-bet 
deficiency had less IL-17 inhibition (3% vs. 26%), and in the absence of both 
transcription factors, IL-17 was no longer inhibited when switched in Tc1 
conditions (Fig 32A).  These data suggest that in the presence of IL-12, Tc17 
cells induce IFN- and turn off IL-17 production through both Stat4 and T-bet 
signals.   
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T-bet levels were also analyzed in these cells and were found to have low 
expression in both five day differentiated Tc17 cells and Tc17-IFN- 
conditions.  T-bet was greatly induced in Tc17Tc1 conditions and this induction 
was decreased in the absence of Stat4 (Fig 32B).   
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Figure 32.  Tc17 plasticity is dependent on both Stat4 and T-bet.  (A,B) WT, 
Tbx21-/-, Stat4-/-, or Tbx21-/- x Stat4-/- CD8+ T cells were stimulated in Tc17 
conditions.  After five days, Tc17 cells were restimulated in the presence of -
IFN- or IL-12 alone for an additional five days.  IL-17, IFN-, and T-bet were 
detected using intracellular cytokine staining after the first round of stimulation 
(Day 5) and also at the end of the second round of stimulation (Day 10).  
Numbers in blue indicate total percentage of IFN- detected and numbers in 
green indicate total percentage of IL-17 detected.  Data are representative of 2 
experiments. 
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In Fig 30B, T-bet played a minimal role in optimal granzyme B expression in Tc1 
cells, but Stat4 was required.  However T-bet correlated with granzyme B 
induction in two week Tc17 cultures (Figs 27 and 29).  Therefore, we wanted to 
determine the requirements of Stat4 and T-bet in granzyme B induction from 
Tc17Tc1 cultures using cells deficient in these transcription factors.  Gene 
deficient CD8 T cells were differentiated into Tc17 cells and after 5 days 
restimulated with neutralizing IFN- antibodies or with IL-12 and cultured for an 
additional 5 days before analysis.  WT Tc17 cells restimulated for a second week 
in neutralizing conditions upregulated granzyme B and this upregulation was not 
dependant on T-bet or Stat4 (Fig 33).  Granzyme B was further induced in WT 
Tc17 cells when they were incubated with IL-12 for a second week of culture.  IL-
12 induced granzyme B was dependent on both T-bet and Stat4 as Tc1 cells 
induced granzyme B to similar percentages as -IFN- conditions in the absence 
of these factors.  Therefore, TCR induction of granzyme B is increased with IL-
12Stat4 and IL-12T-bet signals.   
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Figure 33.  Optimal granzyme B induction in switched Tc17 cells is 
dependent on both Stat4 and T-bet.  (A,B) WT, Tbx21-/-, Stat4-/-, or Tbx21-/- x 
Stat4-/- CD8+ T cells were stimulated in Tc17 conditions.  After five days, Tc17 
cells were restimulated in the presence -IFN or IL-12 for an additional five 
days.  Granzyme B and IL-17 were detected using intracellular cytokine staining 
after the first round of stimulation (Day 5) and at the end of the second round of 
stimulation (Day 10).  Numbers in red indicate total percentage of granzyme B 
detected and numbers in green indicate total percentage of IL-17 detected.  Data 
are representative of 2 experiments. 
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Tc17 cells exist in WT mice 
Tc17 cells are easily induced in vitro upon stimulation in the presence of TGF 
and IL-6.  To determine if IL-17-secreting CD8 T cells exist in vivo, CD8 T cells 
were isolated from the spleens and lymph nodes of Balb/c, C57Bl/6 and C3H 
mice and stimulated with anti-CD3.  We hypothesized that Balb/c CD8 T cells 
would produce higher amounts of IL-17 than C57Bl/6 CD8 T cells because Balb/c 
mice are less prone to produce IFN-.  We were also interested in C3H mice 
because IL-17 has been correlated to tumor development and C3H mice are 
prone to develop mammary tumors.  IL-17 was detectable from splenic CD8 T 
cells of all mouse strains tested and surprisingly, C57Bl/6 CD8 T cells exhibited 
the highest IL-17 expression (Fig 34A).  C57Bl/6 splenic CD8 T cells also 
produced the highest amounts of IFN-.  In general, CD8 T cells isolated from the 
lymph nodes produced lower amounts of both IL-17 and IFN- compared to 
splenic CD8 T cells possibly due to increased naïve and decreased memory CD8 
T cells in the lymph node (Fig 34B).  With respect to lymph node CD8 T cells, the 
most IL-17 was produced by C57Bl/6 CD8 T cells and the most IFN- produced 
by C3H CD8 T cells.  These data demonstrate that Tc17 cells exist in vivo and 
C57Bl/6 mice were used in future experiments due to their higher levels of IL-17-
secreting CD8 T cells.   
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Figure 34.  IL-17-secreting CD8 T cells exist in vivo.  CD8+ T cells were 
isolated from the (A) spleen or (B) lymph nodes of Balb/c, C57Bl/6, or C3H wild 
type mice.  CD8+ T cells were stimulated for 48 hrs and cell free supernatants 
were used to measure IL-17 and IFN- protein levels by ELISA assay.  Results 
are presented as the mean ± SEM of CD8+ T cells from 3 individual mice.  Data 
are representative of 2 experiments. 
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Vaccinia virus infection induces Tc17 cells 
Since Tc17 cells exist in vivo, we next wanted to determine the ability of a viral 
infection to induce Tc17 cells.  Vaccinia virus activates CD8 T cells upon 
infection and also interferes with IFN- signaling to evade the host immune 
system.  To determine if vaccinia virus infection induces Tc17 development, mice 
were infected with vaccinia virus and CD4 and CD8 T cell populations were 
isolated at various time points to determine cytokine production.  Tc17 cells 
increased approximately 3 fold after 14 days of a vaccinia virus infection before 
returning to baseline levels (Fig 35A).  IL-17-secreting CD4 T cells meanwhile 
never significantly rose above baseline levels and were inhibited for the first 
week of infection.  IFN- plays an important role in the control of vaccinia virus 
and was induced in both CD8 and CD4 T cells with a peak at Day 10 post-
infection.  The increase in Tc17 development and IFN- production correlated 
with a decrease in vaccinia virus detected in the ovaries of infected mice (Fig 
35B).   
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Figure 35.  Vaccinia virus induces Tc17 development and IFN- production 
from T cells.  C57Bl/6 mice were infected i.p. with 5x106 pfu vaccinia virus per 
mouse (Day 0).  5, 7, 10, 14, and 21 days postinfection mice were sacrificed and 
ovaries and spleens isolated.  (A) CD8 and CD4 cells were isolated from the 
spleens and restimulated.  IL-17 and IFN- was detected using ICS.  (B)  Viral 
titers were measured from the ovaries of infected mice.  Data corresponds to four 
mice per time point ± SEM. 
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Previous reports have shown that CD8 T cells are dispensable for primary 
vaccinia virus infection, but are important in the memory response to vaccinia re-
infection (Xu et al., 2004).  To determine if Tc17 cells develop in a memory 
response, we infected mice with vaccinia virus and re-infected the mice 3 weeks 
after primary infection.  After another 5 days, cytokine production from T cells 
was analyzed.  Mice infected twice with vaccinia virus induced IL-17 and 
granzyme B from CD8 T cells and IFN- from CD4 T cells (Fig 36).  Smaller or 
insignificant changes were seen in IL-17 and granzyme B from CD4 T cells and 
IFN- from CD8 T cells.  Therefore, Tc17 cells are induced in a memory response 
to vaccinia virus infection in addition to the primary response to vaccinia 
observed in the previous figure.   
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Figure 36.  Tc17 cells are induced in a recall response.  C57Bl/6 mice were 
infected once on Day 0 and infected again 3 wks after the primary infection with 
1x106 pfu vaccinia virus per mouse i.p each time.  Five days after the second 
infection, mice were sacrificed.  CD8 and CD4 cells were isolated from the 
spleens and restimulated before analyzing IL-17 and IFN- production using ICS.  
Data corresponds to 2-4 mice ± SEM. 
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Induction of Vaccinia virus specific Tc17 cells 
B8R is a vaccinia virus protein which contains immunodominant epitopes and 
functions as a soluble IFN- receptor (Seet et al., 2003).  To determine if vaccinia 
virus can induce virus specific Tc17 cells, we analyzed cytokine response upon 
restimulation with a B8R peptide.  Mice were infected for one week before 
isolating CD8 T cells and stimulating with the B8R peptide.  B8R stimulated CD8 
T cells did not produce IL-17 or IFN-, however B8R stimulated CD8 T cells 
produced similar amounts of granzyme B as polyclonally stimulated CD8 T cells 
(Fig 37).  B8R is only one of the immunodominant epitopes of vaccinia virus and 
it is possible that other vaccinia virus epitopes are capable of inducing the Tc17 
cells seen after infection.   
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Figure 37.  Vaccinia virus B8R peptide does not induce Tc17 cells.  C57Bl/6 
mice were infected i.p. with 1x106 pfu vaccinia virus per mouse and sacrificed 
after 7 days of infection.  CD8+ T cells were isolated from the spleen and 
restimulated with B8R peptide or PMA + Ionomycin (P+I).  IL-17, IFN-, and 
granzyme B were detected using ICS.  Data are representative of 2 experiments. 
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To further study antigen specific Tc17 cells in response to vaccinia virus, we 
utilized a vaccinia virus overexpressing an ova peptide with the sequence 
SIINFEKL (VV-SIINFEKL).  CD45.1 congenic mice were injected with naïve OT-I 
cells (CD45.2), infected with VV-SIINFEKL either i.p. or i.n. one day later, and 
sacrificed five days after infection.  After infection, the OT-I cells proliferated 
several fold (Fig 38A, 7% and 21% vs. 0.1%).  Infection induced the OT-I cells 
into a predominantly Tc1 phenotype but also induced a small population of cells 
producing both IL-17 and IFN- (Fig 38A).  The induction in SIINFEKL specific IL-
17 and IFN--secreting CD8 T cells was significant after both i.n. and i.p. infection 
(Fig 38B).   
 
SIINFEKL specific IL-17 and IFN- producing cells was confirmed using an 
ELISA assay.  Total splenocytes obtained in Fig 37A were incubated with 
SIINFEKL peptide for 48 hrs and cell free supernatants were analyzed for IL-17 
and IFN- cytokines.  Antigen specific secretion of IL-17 and IFN- were 
significantly higher in the splenocytes from infected mice compared to control 
mice given PBS (Fig 38C).   
 
Vaccinia virus infection induces a heterogeneous CD8 T cell response.  We 
wanted to analyze induction of additional proinflammatory cytokines and 
cytotoxic molecules and found antigen specific induction of both TNF and 
granzyme B after VV-SIINFEKL infection.  Similar to IL-17 and IFN-, infection via 
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the i.n. route induced higher percentages of both proteins compared to i.p. 
infection (Fig 38D).   
 
To determine if OT-I cells found in the draining lymph nodes of i.n. infected mice 
produce higher percentage of cytokines as OT-I cells found in the spleen, we 
also analyzed the mediastinal lymph node.  Mediastinal lymph nodes, compared 
to the spleen, contained a similar percentage of OT-I cells after i.n. infection and 
a lower percentage of OT-I cells after i.p. infection (Fig 38E vs. 38A).  In addition, 
after an i.n. infection with VV-SIINFEKL, OT-I cells specifically trafficked to the 
mediastinal lymph nodes since they were not found in the distant inguinal lymph 
node (data not shown).  OT-I cells in the mediastinal lymph node produced lower 
amounts of IFN- than in the spleen and IL-17 was not detected at this location. 
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Figure 38.  VV-SIINFEKL infection induces antigen specific Tc17 cells.  BoyJ 
homozygous (CD45.1+) or heterozygous (CD45.1+CD45.2+) mice were injected 
i.v. with 1x106 OT-I / Rag1-/- CD8 T cells.  One day later, mice were infected with 
either 2x106 pfu VV-SIINFEKL i.n. or 2x107 pfu VV-SIINFEKL i.p.  Five days after 
infection, (A) splenocytes were isolated and stimulated with SIINFEKL peptide or 
left unstimulated for a staining control.  IL-17+ and IFN-+ cells were detected 
using ICS and panels on the right are gated on CD45.1-CD45.2+ cells.  (B) Data 
from part (A) are summarized as the average ± SEM from 5 mice.  (C)  
Splenocytes were stimulated with SIINFEKL peptide for 48 hrs and cell free 
supernatants were used to measure IL-17 and IFN- protein levels by ELISA 
assay.  (D) TNF+ and Granzyme B+ cells were detected using ICS and plots are 
gated on CD45.1-CD45.2+ cells.  (E)  Mediastinal lymph nodes were isolated and 
stimulated to detect IFN- and IL-17 using ICS. Plots on the right are gated on 
CD45.1-CD45.2+ cells.  Data corresponds to 5 mice. 
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Along with viral titers in target organs, weight loss is also often used to determine 
the degree of vaccinia virus infection (Verardi et al., 2001; Xu et al., 2004; Jacobs 
et al., 2006).  To determine if weight loss could be utilized in our system as a 
non-terminal measure of viral infection, we tracked weight changes in the mice 
from the previous experiments.   After transfer of naïve OT-I cells and infection 
with VV-SIINFEKL (Fig 38), mice began to lose weight immediately when 
infected intraperitoneally, and began to lose weight after 3 days when infected 
intranasally (Fig 39A).  These weight changes correlated with high viral titers in 
all infected mice (data not shown).  Mice given no infection gained weight from 
the start of the experiment.  When examining longer time points after infection 
with 5x106 pfu per mouse i.p. (Fig 35), infected mice initially lost weight, but this  
trend was reversed around 5 days post-infection when infected mice began to 
gain weight again (Fig 39B).  This data suggested that viral titers could possibly 
be correlated to initial weight loss.  To further examine this correlation, we 
compared viral titers when mice were actively clearing virus (Day 10 and 14, Fig 
35B), with their weight loss on Day 5 (Fig 39B).  The viral titers on Day 10 had an 
increasing trend with increasing weight loss on Day 5 (Fig 39C) as expected; 
however, viral titers on Day 14 had a decreasing trend compared to increasing 
weight loss on Day 5.  Weight loss also did not correlate well with experiments 
done with VV-SIINFEKL; therefore, viral titers in the target organs were 
exclusively utilized in future experiments to determine the degree of vaccinia 
virus infection. 
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Figure 39.  Weight loss induced by vaccinia infection does not correlate 
with viral titers.  (A) Mice were injected with OT-I / Rag1-/- CD8 T cells i.v. and 
infected with VV-SIINFEKL one day later as described in Fig 38.  Mice were 
weighed on Days 0, 3, and 5 and weight change was determined compared to 
weight of the same mouse on Day 0.  Data represent the average ± SEM from 5 
mice. (B) Mice were infected with VV i.p. as described in Fig 35 and weighed on 
Days 0, 5, 7, 10, 14, and 21.  Weight change was determined compared to 
weight of the same mouse on Day 0.  Data represent the average ± SEM from 4 
mice.  (C) Data represent the change in body weight on Day 5 post-infection 
versus viral titers on Day 10 or Day 14.  R2 values were determined from the best 
fit line. 
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Role of IL17 in vaccinia virus clearance 
Previously, we demonstrated that antigen specific Tc17 cells are induced during 
a vaccinia virus infection.  To begin to understand the role of IL-17 in the immune 
response against vaccinia virus, we infected various gene deficient mice with 
defective or enhanced IL-17 production and analyzed viral clearance.   
 
First, we analyzed the ability of Il17a-/- (also referred to as Il17-/-) mice to clear 
vaccinia virus.  Il17-/- had similar viral titers 7 days after infection and lower viral 
titers 11 days after infection (Fig 40A) suggesting that IL-17 inhibits the host 
response to eliminate virus.  CD8 T cells in these mice had significantly low 
levels of IL-17 (using ELISA analysis) and increased IFN- (Fig 40B).  A 
significant decrease in IL-17 production from CD8 T cells was not detected using 
ICS possibly due to the lower sensitivity of this assay.  Granzyme B was not 
affected by the absence of IL-17 and IL-17F was increased in the CD8 T cells 
(Fig 40B).  IL-21 was not detected from the CD8 T cells analyzed (data not 
shown).  CD4 T cells in Il17-/- mice infected with vaccinia virus also have minimal 
IL-17 as expected (Fig 40C).  IFN-, granzyme B, and IL17F are not significantly 
affected and IL-21 is increased in the CD4 T cells.  In addition to the deficiency in 
IL-17A, the altered regulation of several cytokines in Il17-/- mice after vaccinia 
virus infection could contribute to their increased anti-vaccinia response. 
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Figure 40.  Il17-/- mice have increased clearance of vaccinia virus.  (A) Balb/c 
or Il17-/- mice were infected with 5x106 pfu of vaccinia virus per mouse and 
sacrificed either 7 or 11 days after infection.  Ovaries were harvested at the 
indicated time points for viral titers using a plaque forming assay. (B,C) Mice 
were infected with 1x106 pfu of vaccinia virus per mouse and sacrificed 7 days 
after infection.  CD8+ (B) or CD4+ (C) cells were isolated from the spleen.  Cells 
were either restimulated for 4 hrs with PMA + Ionomycin to analyze IL-17, IFN-, 
and granzyme B using ICS (top panels) or restimulated for 24 hrs with -CD3 to 
generate cell free supernatants to analyze IL-17A, IL-17F, IL-21, and IFN- 
protein levels using an ELISA assay (bottom panels).  Data corresponds to 4-5 
mice ± SEM. 
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Role of Stat3 in vaccinia virus clearance 
Since Stat3 is critical for IL-17 secretion from CD4 (Mathur et al., 2007; Yang et 
al., 2007a) and CD8 (Fig 11) T cells, we also analyzed the ability of Stat3CD4-/- 
mice to clear vaccinia virus.  Stat3CD4-/-- had a non-significant trend towards 
increased viral titers 7 days after infection and similar viral titers 11 days after 
infection (Fig 41A).  CD8 T cells in these mice had low levels of IL-17A and IL-
17F and no significant change in IFN- or granzyme B (Fig 41B).  CD4 T cells in 
Stat3CD4-/- mice infected with vaccinia virus produce low levels of the Th17 
cytokines IL-17A, IL-17F, and IL21 as expected (Fig 41C).  Production of 
granzyme B in CD4 T cells of infected mice was not significantly changed; 
however, IFN- was increased.  Altogether, the decreases in Tc17 and Th17 
related cytokines and the increase in IFN- from CD4 T cells did not significantly 
affect the ability of Stat3 deficient mice to clear vaccinia virus.   
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Figure 41.  Stat3CD4-/- mice have normal clearance of vaccinia virus.  (A) 
C57/Bl6 or Stat3CD4-/- mice were infected with 5x106 pfu of vaccinia virus per 
mouse and sacrificed either 7 or 11 days after infection.  Ovaries were harvested 
at the indicated time points for viral titers using a plaque forming assay. (B,C) 
Mice were infected with 1x106 pfu of vaccinia virus per mouse and sacrificed 7 
days after infection.  CD8+ (B) or CD4+ (C) cells were isolated from the spleen.  
Cells were either restimulated for 4 hrs with PMA + Ionomycin to analyze IL-17, 
IFN-, and granzyme B using ICS (top panels) or restimulated for 24 hrs with -
CD3 to generate cell free supernatants to analyze IL-17A, IL-17F, IL-21, and IFN-
 protein levels using an ELISA assay (bottom panels).  Data corresponds to 4-5 
mice ± SEM. 
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Role of T-bet in vaccinia virus clearance 
T-bet is a negative regulator of IL-17 production from CD4 and CD8 T cells 
(Harrington et al., 2005; Park et al., 2005 and Fig 11).  We infected Tbx21-/- mice 
to determine if mice with increased IL-17 have altered clearance of vaccinia 
virus.  Tbx21-/- mice had increased viral titers both 7 and 11 days after infection 
(Fig 42A).  CD8 T cells in these mice had increased production of IL-17, 
decreased IFN-, and no change in granzyme B (Fig 42B).  A previous report 
(Matsui et al., 2005) observed a decreased ability of Tbx21-/- mice to control 
vaccinia virus infection which was partially attributed to an increased production 
of IL-4 in addition to diminished function of VV specific CTLs.  Consistent with 
this, we also observed an increased production of IL-4 from CD8 T cells in 
Tbx21-/- mice after vaccinia virus infection (Fig 42B).  CD4 T cells in Tbx21-/- mice 
infected with vaccinia virus produce higher levels of IL-17, decreased IFN-, and 
no change in granzyme B (Fig 42C).  Therefore, in addition to the changes in 
IFN- and IL-4 previously reported, IL17 induction may also contribute to the 
defective host response against vaccinia virus in Tbx21-/- mice.   
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Figure 42.  Tbx21-/- mice have decreased clearance of vaccinia virus.  
C57Bl/6 or Tbx21-/- mice were infected with 5x106 pfu of vaccinia virus per mouse 
and sacrificed either 7 or 11 days after infection.  (A) Ovaries were harvested at 
the indicated time points for viral titers using a plaque forming assay.  (B) CD8+ 
cells were isolated from the spleen.  Cells were either restimulated for 4 hrs with 
PMA + Ionomycin to analyze IL-17, IFN-, and granzyme B using ICS (top 
panels) or restimulated for 24 hrs with -CD3 to generate cell free supernatants 
for analysis of IL-17, IFN-, and IL-4 protein levels using an ELISA assay (bottom 
panels).  (C) CD4+ cells were isolated from the spleen and restimulated for 4 hrs 
with PMA + Ionomycin.   IL-17+, IFN-+, and granzyme B+ cells were detected 
using ICS.  Data corresponds to 4-5 mice ± SEM. 
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Antiviral activity of adoptively transferred Tc17 cells 
To more directly determine the function of Tc17 cells in vivo and their potential 
role in anti-vaccinia immunity, we performed adoptive transfer experiments with 
in vitro differentiated Tc17 cells and VV-SIINFEKL infected hosts.  CD45.2 OT-I 
CD8 T cells were differentiated for 5 days in Tc17 conditions before i.v. transfer 
into CD45.1 hosts.  Mice were infected i.n. with VV-SIINFEKL one day after T cell 
transfer and analyzed 4 days after infection.  Infected mice which received Tc17 
cells had a trend towards lower vaccinia virus titers in the lung, similar to infected 
mice which received Tc1 cells (Fig 43A).  After a systemic infection, vaccinia 
virus preferentially localizes to the ovaries (Huang et al., 1993; Muller et al., 
1994), however was not detected in the ovaries of any mice after i.n. infection 
(data not shown).  In the infected mice, there was a larger migration to the 
draining lymph nodes of transferred Tc17 cells compared to transferred Tc1 cells 
and more Tc1 cells were detected in the spleens (Fig 43B).  However, in both 
locations, OT-I Tc1 cells had a greater dilution of CFSE and proliferated to a 
greater extent than OT-I Tc17 cells.  To determine if Tc17 cells secrete 
characteristic Tc17 cytokines after viral challenge in vivo or have an unstable 
phenotype as previously seen in vitro (Fig 26), we analyzed cytokine production 
from transferred cells detected in the spleen.  After 4 days of infection with VV-
SIINFEKL, IL-17 production from Tc17 cells was maintained while a portion of IL-
17-secreting CD8 T cells also began to produce IFN-.  Tc1 cells secreted a 
higher percentage of IFN- after adoptive transfer.  These data suggest that Tc17 
cells are potentially anti-viral in vivo and are unstable after viral challenge. 
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Figure 43.  Adoptively transferred Tc17 cells reduce an i.n. VV-SIINFEKL 
infection and are unstable.  Five day differentiated Tc17 or Tc1 cells (1x106, 
CD45.2) or PBS were injected i.v. into BoyJ (CD45.1+) mice.  Cells were also 
labeled with CFSE immediately prior to adoptive transfer.  One day later, mice 
were infected with 2x106 pfu VV-SIINFEKL i.n.  Four days after infection, (A) 
lungs were harvested to determine viral titers using a plaque forming assay.  (B) 
Single cell suspensions from mediastinal lymph nodes (left panels) and spleens 
(right panels) were surface stained with CD45.1 and CD45.2 to identify 
transferred cells.  Bottom panels are gated on CD45.1-CD45.2+ cells and display 
CFSE dilution of transferred Tc17 and Tc1 cells.  (C) IL-17+ and IFN-+ cells were 
identified in 5 day differentiated Tc17 or Tc1 cells immediately before adoptive 
transfer (left panels) and five days after adoptive transfer (or four days after 
infection, right panels).  Transferred cells in the right panels are gated on the 
CD45.1-CD45.2+ cells illustrated in the middle panels.  Data corresponds to 4-7 
mice ± SEM or are typical representatives of the experimental group. 
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One function of IL-17 is to attract innate immune cells, especially neutrophils, to 
the site of an infection.  To determine if adoptively transferred Tc17 cells 
attracted an inflammatory infiltrate into the lungs of VV-SIINFEKL infected mice, 
histological lung sections were analyzed.  Tc17 cells or PBS was transferred into 
mice which were infected one day later with VV-SIINFEKL as in Fig 43.  Four 
days after infection, mice were sacrificed.  Lung sections from infected mice 
which had received PBS showed a perivascular inflammatory infiltrate in some 
areas consisting of both mononuclear and polymorphonuclear cells including 
eosinophils (Fig 44A).  Infected mice which had received Tc17 cells appeared to 
have increased inflammation with a similar composition, however histological 
slides were not scored.  To quantitate lung inflammation, we counted cell 
numbers in the BAL fluid and analyzed the percentage of BAL neutrophils (Fig 
44B).  Infected mice which received Tc1 cells had a significantly increased 
number of BAL cells and infected mice which received Tc17 cells had an 
increased trend in neutrophils in their BAL fluid, although this trend was not 
statistically significant.  Smallpox vaccinations in military personnel have been 
associated with rare cases of myopericarditis (Maurer et al., 2003); however 
inflammatory infiltrates were not detected in the hearts of any of the mice 
examined.   
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Figure 44.  VV-SIINFEKL infection induces lung inflammation.  Mice were 
injected with Tc17 or Tc1 cells or PBS i.v. and infected with VV-SIINFEKL one 
day later as described in Fig 43.  Four days after infection (A) lung sections were 
fixed and stained with H&E.  Two different magnifications are shown of lung 
sections from infected mice given PBS or Tc17 cells and the corresponding viral 
titers are displayed on the right side of the slides.  (B)  Cell numbers in the BAL 
fluid were counted (left panel) and surface stained (right panel). Neutrophils were 
determined as B220-CD3-FSCloCCR3- cells. Data corresponds to 4-5 mice ± 
SEM or representative slides. 
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In the previous figures (Figs 43 and 44), we utilized an intranasal infection model 
to localize vaccinia virus infection and to mimic natural vaccinia virus infection.  
However, our results with viral titers and inflammation were often inconsistent.  
Therefore, we switched to an intraperitoneal infection route for VV-SIINFEKL to 
determine the function of adoptively transferred Tc17 cells.  Mice were infected 
i.p. with VV-SIINFEKL and one day after infection, 5 day differentiated Tc17 or 
Tc1 cells were transferred into the infected mice.  Mice were sacrificed 6 days 
after T cell transfer (which was also 7 days after infection).  Infected mice which 
received Tc17 cells had significantly lower vaccinia virus titers in their ovaries 
compared to infected mice which received PBS (Fig 45A).  Adoptively transferred 
Tc17 cells reduced viral load to similar levels as transferred Tc1 cells and more 
Tc17 cells were detected in the spleens of infected cells compared to Tc1 cells 
(Fig 45B).  Similar to Tc17 cells transferred into i.n. infected mice, Tc17 cells 
transferred into i.p. infected mice were unstable and upregulated IFN- after 
encounter with VV-SIINFEKL (Fig 45C).  An increase in neutrophils was not 
detected in the blood or spleens of mice which received Tc17 cells (Fig 45D).  
Therefore, Tc17 cells are protective against vaccinia virus infection through 
mechanisms possibly involving IFN-. 
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Figure 45.  Adoptively transferred Tc17 cells are antiviral against an i.p. VV-
SIINFEKL infection.  BoyJ (CD45.1) mice were infected with 2x107 pfu VV-
SIINFEKL i.p. and injected i.v. with five day differentiated Tc17 or Tc1 cells 
(1x106, CD45.2) or PBS one day later.  After an additional six days, (A) ovaries 
were harvested for viral titers.  (B) Splenocytes were surface stained with CD45.1 
and CD45.2 to identify transferred cells.  (C) IL-17+ and IFN-+ cells were 
identified in 5 day differentiated Tc17 or Tc1 cells immediately before adoptive 
transfer (left panels), three and six days after adoptive transfer (middle and right 
panels).  Transferred cells in the middle and right panels are gated on CD45.1-
CD45.2+ cells. (D) After one week of infection, neutrophils were analyzed in the 
blood and spleen of infected mice.  Neutrophils were gated on CD11bhiGr-1hi 
cells.  Data corresponds to 4-5 mice ± SEM or are typical representatives of the 
experimental group. 
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Role of IFN- in Tc17 mediated viral clearance 
IFN- plays a critical role in the clearance of vaccinia virus and mice deficient in 
IFN- signaling are highly susceptible to vaccinia infection (Huang et al., 1993; 
Muller et al., 1994).  To determine if IFN- induction in Tc17 cells was responsible 
for Tc17 mediated viral clearance, we repeated the previous experiment with 
Ifng-/- Tc17 cells.  Mice were infected i.p. with VV-SIINFEKL and one day after 
infection, 5 day differentiated OT-I Tc17 or OT-I Ifng-/- Tc17 cells were transferred 
into the infected mice.  Mice were sacrificed 6 days after T cell transfer or 7 days 
after infection.  The decrease in IL-17 and induction of IFN- in transferred Tc17 
cells was confirmed using ICS (Fig 46A).  Ifng-/- Tc17 did not upregulate IFN- as 
expected and transferred Tc17 cells did not upregulate granzyme B.  WT and 
Ifng-/- Tc17 induced T-bet to similar levels.  Tc17 cells deficient in IFN- were able 
to clear vaccinia virus as efficiently as wild type Tc17 cells (Fig 46B) indicating 
that Tc17 cells are able to clear vaccinia virus via an IFN- independent 
mechanism.     
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Figure 46.  Adoptively transferred Tc17 cells are antiviral via an IFN- 
independent mechanism.  BoyJ mice were infected with 2x107 pfu VV-
SIINFEKL i.p. and injected i.v. with five day differentiated Tc17 or Tc1 cells 
(1x106) or PBS one day later.  After an additional six days, (A) IL-17+, IFN-+, 
granzyme B+, and T-bet+ cells from the CD45.1-CD45.2+ gate were determined 
using ICS.  Median values are displayed as horizontal lines and diamonds 
represent individual mice (B) Ovaries were harvested for viral titers.  Data 
corresponds to 4-5 mice ± SEM. 
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Cytotoxic potential of Tc17 cells after VV-SIINFEKL challenge 
After restimulation in the presence of IL-12 in vitro, Tc17 cells upregulate IFN- 
and gain cytotoxic function.  To determine if Tc17 cells can become cytotoxic 
during a VV-SIINFEKL infection, we reisolated adoptively transferred cells from 
infected hosts to test in a killing assay.  Mice were infected i.p. with VV-SIINFEKL 
and one day after infection, 5 day differentiated Tc17 or Tc1 cells were 
transferred into the infected mice.  After another 6 days, adoptively transferred 
cells were isolated based on their expression of CD45.2 and tested in a 
chromium release assay.  After encounter with VV-SIINFEKL in vivo, Tc1 cells 
remain cytotoxic and Tc17 cells also gained cytotoxic ability (Fig 47A).  As seen 
previously, the Tc17 cells expressed low levels of IL-17 and did not upregulate 
granzyme B (Fig 47B).  Upregulation of IFN- was not observed in these Tc17 
cells and we believe this was due to a technical issue of restimulating isolated 
cells with peptide alone instead of peptide with APCs.  Thus, Tc17 cells become 
cytotoxic during clearance of vaccinia virus from infected mice. 
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Figure 47.  Tc17 cells become cytotoxic after encountering vaccinia virus in 
vivo.  Mice were infected with VV-SIINFEKL and injected with Tc17 or Tc1 cells 
as described in Fig 45.  Injected cells were isolated after an additional six days 
using PE conjugated anti-CD45.2 antibodies and anti-PE microbeads.  (A) 
Effector cells were added at increasing ratios to ova expressing EG.7 target cells 
or nonspecific EL4 target cells labeled with Cr51 and incubated for 6 hrs before 
measuring Cr51 released into the supernatant.  (B) CD45.2 enriched cells were 
stained with CD45.1 to determine purity.  IL-17+, IFN-+, and granzyme B+ cells 
were determined using ICS.  Data corresponds to 4-5 mice ± SEM or are typical 
representatives of the experimental group. 
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Summary of the antiviral potential of Tc17 cells 
We propose a model of CD8 T cell mediated clearance of vaccinia virus as 
depicted in Fig 48.  Upon recognition of an infected cell, a vaccinia virus specific 
CD8 T cells undergo clonal expansion to divide several fold.  In the presence of 
IL-12, Tc1 cells are formed which likely mediate cell killing through IFN- 
dependant mechanisms.  If TGF and IL-6 are present in the environment, a 
transient Tc17 cell develops which acquires a Tc1 phenotype upon reencounter 
with virus.  Tc17 cells are clearly able to mediate viral clearing, however the role 
of its cytotoxic potential and unique phenotype are still unknown.   
 148
IL-12
Tc1
T-bet
CD8+
IFN-
Perforin
Granzyme B
Tc17
Stat3
TGF
+ IL-6 IL-17
IL-22
IL-21
Tc17
Tc1
IL-17
IFN-
(cytotoxic)
STAT4
T-bet
IF
N
-
IF
N
-
IL-17
IL-17
IF
N
-
IF
N
-
 
 
 
Figure 48.  CD8 T cell clearance of vaccinia virus.  Vaccinia virus specific 
CD8 T cells develop into a heterogeneous population after stimulation by 
vaccinia virus epitopes.  Some develop into IFN-g expressing Tc1 cells while 
others secrete IL-17.  IL-17 secreting CD8 T cells subsequently acquire cytotoxic 
potential and secrete IFN- as they mediate viral clearance.   
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IL-23 maintains IL-17 secretion without affecting Th17 cell proliferation or 
expansion 
Although the requirement for IL-23 in the function of Th17 cells in vivo is 
established, the precise role of this cytokine in affecting the Th17 phenotype is 
unclear. Among other functions, IL-23 was proposed to act as a Th17 cell 
proliferation or survival factor. To directly test these functions, we developed a 
cytokine capture assay for IL-17-secreting cells to compare IL-23 functions in 
enriched IL-17-high and low secretor populations. Naive CD4 T cells were 
cultured with TGF-1+IL-6+IL-1 for 5 days before stimulation with anti-CD3 
before selection of IL-17-high and low cells by cell sorting (Fig 49A). Following 
sorting there was a 10–12-fold enrichment for IL-17 secreting cells in the IL-17-
high population (Fig 49A). The separation of cells into distinct populations was 
confirmed by demonstrating segregated expression of IL-17, IL-22, Il23r, and 
Rorc, while IFN- production was indistinguishable between the two populations 
(Fig 49 B, C). Intracellular staining for IFN-  in these populations demonstrated 
less than 0.5% in any population (data not shown).  
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Figure 49.  Cytokine selection of IL-17+ Th17 cells.  (A), Naive CD4+ T cells 
were activated, cultured in TGF- plus IL-6 plus IL-1 and blocking Abs (anti-IFN-
 and anti-IL-4) for 5 days and activated before surface staining for IL-17 using 
cytokine capture. Cells were then sorted into IL-17-high and low populations. (B), 
Supernatants from IL-17-high and -low cells stimulated with anti-CD3 were tested 
for cytokines using ELISA. (C), RNA was isolated from cells treated in (B) and 
gene expression was assessed using real-time PCR.  Data correspond to 2 
experiments. 
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One of the proposed functions of IL-23 is promoting the proliferation or expansion 
of Th17 cells. To test this directly, naive CD4 T cells were cultured with TGF-
+IL-6+IL-1 for 5 days, separated based on IL-17 production and labeled with 
CFSE (Fig 50A). CFSE-labeled IL-17-high and low populations were cultured in 
blocking Abs (anti-IFN- and anti-IL-4) alone or blocking Abs plus IL-23 for 24 or 
48 h to assess proliferation. Although IL-17-high cells had an intrinsically higher 
rate of proliferation than IL-17-low cells, there was not a significant difference in 
proliferation between cultures incubated with or without IL-23 (Fig 50 B, C), 
suggesting that IL-23 does not promote a robust proliferative response. 
 
IL-23 was also proposed to affect Th17 survival. However, in examining the 
overall cell growth in IL-17-high and low cells, we observed the increased 
proliferative capacity of IL-17-high cells that resulted in a 2–3-fold increase in cell 
number compared with IL-17-low cells, but only minor effects of IL-23 (Fig 50D). 
Similarly, IL-17-high and low cells cultured in the presence or absence of IL-23 
had similar percentages of Annexin V+ cells after 2 or 4 days of culture with little 
effect of IL-23 culture (Fig 50E).  
 
In contrast, we did note that in IL-17-high populations cultured with IL-23, a 
higher percentage of cells, with a higher intensity of IL-17 staining, was 
maintained compared with cells cultured in the absence of IL-23 (Fig 50B). The 
effects of IL-23 on maintaining the IL-17-secreting phenotype were even more 
dramatic when cells were activated with anti-CD3. After 2 days of activation, IL-
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17-high cells cultured in IL-23 still had >60% IL-17+ cells, while cultures 
incubated in the absence of IL-23 has <30% IL-17+ cells (Fig 50F). This effect 
was also observed in the IL-17-low cultures where IL-17+ cells comprised <10% 
of the population when cultured in the absence of IL-23 (Fig 50F). These data 
suggest that IL-23 maintains the IL-17-secreting phenotype without detectable 
effects on Th17 cell proliferation or expansion.  
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Figure 50.  IL-23 maintains the IL-17-secreting phenotype without affecting 
cell expansion or survival.  (A), Naive CD4+ T cells were activated, cultured in 
TGF- plus IL-6 plus IL-1 and blocking Abs (anti-IFN- and anti-IL-4) for 5 days 
before sorting into IL-17-high and low populations. Cells were then labeled with 
CFSE and for intracellular IL-17 following stimulation with PMA plus ionomycin. 
Numbers indicate percent of cells in each quadrant and bracketed numbers 
indicate CFSE mean fluorescence intensity. (B), IL-17-high cells were cultured 
with IL-23 and blocking Abs or blocking Abs alone for the indicated times before 
cells were stimulated and stained for intracellular IL-17. Numbers indicate 
percent of cells in each quadrant and bracketed numbers indicate CFSE mean 
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fluorescence intensity. (C), IL-17-high or -low CFSE-stained cells prepared as in 
(B) were cultured for 2 days with blocking Abs in the presence or absence of IL-
23 as indicated. CFSE staining is shown from freshly stained cells (day 0) for 
comparison. (D), IL-17-high and -low cells cultured as in (B) were counted after 
48 h. (E), IL-17-high and -low cells were cultured as in (B) and were analyzed for 
Annexin V staining after 2 or 4 days of culture in the presence or absence of IL-
23. (F), IL-17-high and-low cells were stimulated with anti-CD3 and cultured with 
blocking Abs with or without IL-23. Cells were stimulated with PMA plus 
ionomyocin for 4 h and stained for intracellular IL-17.  Data correspond to 2 
experiments. 
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IL-23 maintains the Th17 phenotype in long-term cultures 
To test the ability of IL-23 to maintain the Th17 phenotype over long term culture, 
we cultured naive CD4 T cells for 1 wk with TGF- plus IL-6 plus IL-1, the latter 
which we found amplifies IL-23 responsiveness in vitro (Veldhoen et al., 2006 
and data not shown), and then for subsequent rounds of stimulation with either 
blocking Abs alone or IL-23 with blocking Abs. Despite a high level of IL-17 in the 
initial cultures, IL-23 was only partially effective in attenuating the decrease of IL-
17 production from T cells following subsequent rounds of stimulation, compared 
with blocking Abs alone (Fig 51A). IL-23 was effective in limiting IFN-  production 
from these cultures suggesting that the decrease in IL-17 production observed 
over multiple rounds of stimulation is not due to coincident increases in IFN- 
production or increases in the percentage of cells that are IFN-+.  
 
Given the similarity in autoimmune disease phenotype between IL-1RI- and IL-
23p19-deficient mice, and that IL-1 enhances IL-23 responsiveness (Cua et al., 
2003; Cho et al., 2006; Sutton et al., 2006), we next tested the ability of IL-1 to 
cooperate with IL-23 in long term cultures. Naive CD4 T cells were cultured as in 
Fig 3A for the first week and then cultured for subsequent rounds of stimulation 
with IL-23, IL-1, or a combination of IL-23 and IL-1. Although IL-1 was no 
more effective than IL-23 in attenuating the loss of IL-17 secretion over multiple 
rounds of stimulation, the combination of IL-23 and IL-1 was able to maintain a 
high level of IL-17 secretion over three rounds of stimulation (Fig 51B). There 
were not dramatic differences in the growth or survival among these cultures 
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over several rounds of culture (data not shown), suggesting that the effects of 
these cytokines are not on survival or expansion, but rather on maintaining the 
phenotype of the cells. The combination of IL-23 and IL-1 was similarly capable 
of maintaining higher levels of IL-21 and IL-22 secretion than IL-23 alone, 
although there were decreases in these cytokines over rounds of stimulation (Fig 
51B). 
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Figure 51.  IL-1 increases IL-23 stimulated maintenance of the Th17 
phenotype.  (A), Naive T cells were activated, primed with TGF- plus IL-6 plus 
IL-1 for the first round and cultured for two additional rounds of stimulation in the 
presence of blocking Abs with or without IL-23. After each round of culture cells 
were stimulated and cell-free supernatants were tested for cytokine production 
using ELISA. (B), Naive T cells were activated and primed as in (A) and cultured 
for two additional rounds of stimulation with IL-23, IL-1, or IL-23 plus IL-1 as 
indicated. Cytokine production was measured using ELISA.  Data correspond to 
2 experiments. 
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To define the mechanism for the ability of IL-1 to augment IL-23 function we first 
analyzed IL-23R expression in cells cultured with IL-23, IL-1, or both cytokines 
for the second and third rounds of stimulation. Although culture with IL-23 
maintained or enhanced Il23r mRNA expression, there was no increased 
expression in cells cultured with IL-1 alone or with both cytokines (Fig 52A). We 
then examined IL-23 signaling using flow cytometry to assess levels of phospho-
Stat3 following acute stimulation of cultures incubated for three rounds in IL-23, 
IL-1, or both cytokines. IL-23 stimulated Stat3 phosphorylation in cells from 
each of the conditions with insignificant differences in the phospho-Stat3 levels 
among the conditions, suggesting that the effect of IL-1 was not altering IL-23 
signaling (Fig 52B). To test whether IL-1 had altered the Il17 gene to make it 
more responsive to IL-23, we took advantage of an assay we previously 
described for the acute stimulation of IL-17 production by a combination of IL-23 
and IL-18 (Mathur et al., 2007). Naive CD4 T cells primed with TGF- plus IL-6 
plus IL-1 for the first round of stimulation and cultured in IL-23 or IL-23 plus IL-
1 for two rounds of stimulation were restimulated with IL-23 plus IL-18. Cells 
that were cultured with IL-23 plus IL-1 generated higher amounts of IL-17 than 
cells cultured in IL-23 alone in response to IL-23 plus IL-18 (Fig 52C). Because 
analysis of Il23r expression in these cultures (Fig 52A) showed only minor 
differences in expression, with slightly lower levels in the IL-23 plus IL-1 
cultured cells, it suggests that culture in IL-23 plus IL-1 is directly affecting the 
responsiveness of the Il17 locus, although we did not find differences in the level 
of total histone acetylation between cells that were cultured with or without IL-1 
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(data not shown). IL-1 may enhance IL-23 function by activating cooperative 
transcription factors, or through indirect mechanisms including the ability to limit 
the inhibitory effects of IL-2 on Th17 development (Kryczek et al., 2007a).  
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Figure 52.  IL-1 increases responsiveness of the IL-17 locus.  (A), Naive T 
cells were activated, primed with TGF- plus IL-6 plus IL-1 for the first round 
and cultured for two additional rounds of stimulation with IL-23, IL-1, or IL-23 
plus IL-1 as indicated. At the end of the first, second, and third round of 
stimulation RNA was isolated from cells stimulated with anti-CD3 for 4 h. 
Quantitative PCR of Il23r expression is shown as relative to Th1 cultures after 
the third round of stimulation. (B), Cells cultured and stimulated as in (A) for three 
rounds were stimulated with IL-23 for 30 min before intracellular staining for 
phospho-STAT3. (C), Naive cells primed and cultured as in (A) were stimulated 
with IL-18 and IL-23 for 24 h. Cell-free supernatants were measured for IL-17 
using ELISA.  Data correspond to 2 experiments. 
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IL-23 does not mediate commitment to the Th17 lineage 
Because IL-23 was capable of maintaining the IL-17-secreting phenotype, it 
allowed us to determine whether IL-23 mediated commitment to the Th17 
lineage, with commitment being defined as the ability of cells to maintain the IL-
17-secreting phenotype in the presence of cytokines promoting the development 
of other subsets. Th1 and Th2 cells are committed to their respective lineages 
after three rounds of stimulation (Murphy et al., 1996). Naive CD4 T cells were 
primed with TGF- plus IL-6 plus IL-1 for the first round, cultured for two rounds 
in IL-23 plus IL-1, and then either maintained in IL-23 plus IL-1 or switched to 
IL-12 or IL-4 containing medium for the fourth round of stimulation before 
stimulation with anti-CD3 to assess cytokine production. Although cells cultured 
for the fourth round in IL-23 plus IL-1 maintained the ability to produce IL-17, 
cells switched to Th1 or Th2 promoting conditions showed diminished IL-17 
production and the induction of IFN- and IL-4, respectively (Fig 53 A, B). Similar 
results were generated using cultures derived from C57BL/6 or BALB/c mice 
(data not shown). The levels of IL-4 induced following switching into Th2 
conditions were lower than seen from cells cultured for 4 wk under Th2 
conditions, though the levels of IFN- secreted by Th17 cultures switched to Th1 
conditions were comparable to long term Th1 cultures (Fig 53 A, B). Expression 
of other Th17 genes including Il17f, Il23r, Il22, and Rorc were also diminished in 
cultures switched to Th1 or Th2 conditions (Fig 53 C, D). In contrast, naive CD4 
T cells primed with TGF- plus IL-6 plus IL-1 for the first round, cultured for two 
rounds in IL-23 plus IL-1, and subsequently switched to culture conditions that 
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promote Treg development were unable to develop into Foxp3-expressing cells 
(Fig 53E). Culture of cells with TGF plus IL-2 increased the percentage of IL-17+ 
cells. Thus, Th17 cells cultured with IL-23 can adopt some, but not all CD4 T cell 
lineages.  
 
Although T cells cultured for three rounds under these Th17 conditions produce 
large amounts of IL-17, there is still some production of IFN-, and it remained 
possible that a contaminating population of cells was expanding and overtaking 
the Th17 cells upon switching cultures to Th1 or Th2 conditions. To eliminate this 
possibility, we used the cytokine capture protocol to isolate IL-17-high cells from 
Th17 cultures after three rounds of stimulation (Fig 53F) and then maintained the 
cultures with IL-23 plus IL-1 or switched to conditions promoting Th1 or Th2 
development. As observed with unseparated Th17 cultures, IL-17-high cells 
maintained their phenotype with continued culture in IL-23 plus IL-1, but showed 
decreased IL-17 and IL-22 production, and increased IFN- and IL-4 production 
in Th1 and Th2 conditions, respectively (Fig 53 G, H). Thus, IL-17-high cells are 
not stable secretors of IL-17 and upon exposure to conditions promoting the 
development of other Th subsets, they acquire new cytokine secreting 
characteristics. 
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Figure 53.  IL-23 does not program commitment to the Th17 lineage.  (A), 
Naive T cells were activated, primed with TGF- plus IL-6 plus IL-1 for the first 
round followed by two rounds of stimulation in IL-23 plus IL-1, were cultured for 
an additional round of stimulation in Th1 or Th2 conditions, or IL-23 plus IL-1. 
Supernatants from anti-CD3 stimulated cells were tested for cytokine production 
using ELISA. (B), Naive CD4+ T cells were activated and cultured under Th1 or 
Th2 priming conditions for four rounds of stimulation. At the end of the fourth 
round of stimulation, supernatants from anti-CD3 stimulated cells were tested for 
cytokine production using ELISA. (C), Cells stimulated and cultured as in A were 
stimulated with anti-CD3 for 4 h and RNA was isolated for quantitative PCR. (D), 
Cells were stimulated and cultured for three rounds as in (A). After 3 days of 
culture in Th1, Th2, or IL-23 plus IL-1 conditions, RNA was isolated from control 
or switched cultures for quantitative PCR. (E), Naive T cells were activated, 
primed with TGF- plus IL-6 plus IL-1 for the first round followed by two rounds 
of stimulation in IL-23 plus IL-1, were cultured for an additional round of 
stimulation in IL-23 plus IL-1 or TGF- plus IL-2. The percentages of cells 
positive for Foxp3 or IL-17 intracellular staining are indicated with cells cultured 
for 1 wk in TGF plus IL-2 shown as a control for Foxp3 expression. (F), Naive 
CD4+ T cells were primed and cultured as in A, and after the third round of 
culture, cells were enriched for IL-17-secreting cells by cytokine selection. 
Surface staining for IL-17 is shown pre- and post sort. (G), IL-17-high cells from 
(F) were cultured in Th1, Th2, or IL-23 plus IL-1 for an additional round of 
stimulation. Cells were stimulated for 4 h and stained for intracellular IL-17 and 
IFN-. (H), Supernatants from anti-CD3 stimulated cells cultured as in (G) were 
tested for cytokine production using ELISA.  Data correspond to 2 experiments. 
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We then defined if the switch from Th17 to Th1 or Th2 was characterized by 
induction of the standard pathways and lineage determining factors. IL-4 
signaling is qualitatively altered in Th1 cells through mechanisms that are still not 
clear but do not involve altered Stat6 activation (Huang and Paul, 1998), and IL-4 
was able to activate Stat6 in cells cultured under Th1, Th2, or Th17 conditions 
(Fig 54A). During Th2 development, IL-12 signaling is extinguished, contributing 
to commitment in the Th2 lineage (Szabo et al., 1997). However, while Il12rb2 
expression was greatly decreased in cells cultured for three rounds in Th2 
conditions, cells cultured in IL-23 plus IL-1 demonstrated expression of Il12rb2 
similar to Th1 cells (Fig 54B). To determine whether IL-12 signaling was 
functional, we examined Stat4 expression and IL-12-induced phosphorylation of 
Stat4 in Th1, Th2, and Th17 cultures after three rounds of stimulation. Although 
Stat4 expression is reduced and IL-12-induced Stat4 phosphorylation is 
eliminated in Th2 cultures, normal expression of Stat4 was retained in Th17 
cultures. IL-12-induced Stat4 activation was only modestly diminished in IL-23 
plus IL-1 and IL-23 cultured cells compared with Th1 cultures (Fig 54C). Despite 
the reduction in IL-12-induced Stat4, IL-12 and IL-4 were still able to promote an 
increase in Tbx21 and Gata3 expression in Th17 cultures switched to Th1 or Th2 
conditions, respectively (Fig 54D). Thus, Th17 cells, even after long-term culture, 
are competent to assume a Th1 or Th2 phenotype.  
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Figure 54.  Signals promoting Th1 or Th2 development are intact in Th17 
cultures.  (A), Cells stimulated and cultured as in Fig 51, (A) and (B) were 
incubated with IL-4 for 30 min and stained for phospho-Stat6. (B), RNA from cells 
stimulated as in (A) for three rounds of stimulation was examined for relative 
levels of Il12rb2 expression. Levels are relative to three-round Th1 cultures. (C), 
Cells stimulated and cultured as in (A) for three rounds of stimulation were then 
stimulated with IL-12 for 1 h. Phospho-Stat4, total Stat4, and actin were detected 
by immunoblot. (D), Cells were stimulated and cultured for three rounds as in (A). 
After 3 days of culture in Th1, Th2, or IL-23 plus IL-1, RNA was isolated from 
control or switched cultures for quantitative PCR to test for expression of the 
indicated genes. Expression is relative to the level of expression of each gene in 
IL-23 plus IL-1 cultured cells before the fourth round of culture.  Data 
correspond to 2 experiments.  
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DISCUSSION 
Development of IL-17 secreting CD4 and CD8 T cells 
Within the past 5 years Th17 cells have been discovered to be important 
mediators of inflammation including autoimmune diseases such as EAE 
(experimental autoimmune encephalomyelitis), a mouse model of multiple 
sclerosis.  Cytokines and transcription factors regulating Th17 development are 
now fairly well established, making the factors that regulate IL-17 secretion from 
CD4 T cells an ideal framework for the study of IL-17 secretion from other cell 
types.  IL-17 secreting CD8 T cells have been observed in several in vivo 
models; however the specific conditions and molecular mechanisms necessary 
for their development in vitro have not been fully elucidated.  Similar to Th17 
development, our data demonstrate that Tc17 development requires either IL-6 
or IL-21 in combination with TGF, and STAT3.  RORt is also correlated with 
and can induce IL-17 secretion from CD8 T cells.  Meanwhile, Tc17 development 
is inhibited by IFN-, STAT1, and T-bet.  These observations regarding Tc17 
regulation are consistent with several recent reports (Ciric et al., 2009; Hamada 
et al., 2009; Huber et al., 2009; Yen et al., 2009) which have also demonstrated a 
positive role in Tc17 development for IL-1 and TNF.  Other studies have shown 
inhibition of Tc17 development by IL-2, IL-27, and Type I interferons (Stumhofer 
et al., 2006; Curtis et al., 2009; Hamada et al., 2009).  Altogether, similar 
regulation suggests that IL-17 inducing environments can induce both Th17 and 
Tc17 cells depending on the antigen presentation pathway.  Indeed, both Th17 
cells and Tc17 cells have been detected in infectious models of Klebsiella 
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pneumonia (Happel et al., 2003) and LCMV (Intlekofer et al., 2008) in addition to 
autoimmune models of contact hypersensitivity (He et al., 2006) and EAE (Huber 
et al., 2009).  Similar regulation also suggests that mechanisms to inhibit IL-17 
mediated pathologies would inhibit IL-17 secretion from both CD4 and CD8 T 
cells.  This has been seen with T-bet and IL-27 mediated IL-17 inhibition in 
infectious models of Trypanosoma cruzi and Toxoplasma gondii respectively 
(Stumhofer et al., 2006; Guo et al., 2009).  The emergence of IL-17 secreting 
CD8 T cells in vivo during inflammation implicate Tc17 cells as important 
mediators of IL-17 related pathologies and expose possible roles of IL-17 in CD8 
T cell mediated functions.   
 
Transcriptional regulation of IL-17 and IFN- secreting CD8 T cells 
CD8 T cells mediate their functions through cytokine secretion and acquire the 
potential to secrete various cytokines after activating lineage specific 
transcription factors and proteins in the Stat signaling family.  Utilizing gene 
deficient mice and siRNA, we and others (Huber et al., 2009; Yen et al., 2009) 
have demonstrated the critical role of Stat3 in Tc17 development.  In addition, 
Stat3 is necessary for optimal expression of RORt expression which can induce 
IL-17 production even in non-optimal conditions (Fig 14 and Huber et al., 2009). 
 
IL-17 secreting cells have also been shown to be induced by Stat4 downstream 
of IL-23 (Mathur et al., 2007).  IL-23 activates both Stat3 and Stat4 (Parham et 
al., 2002) and it is possible that Tc17 cells in vivo are induced through both TGF 
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/ IL-6 and IL-23 mediated pathways.  Indeed, we found IL-23 promoted a small 
population of IL-17 secreting cells from a naïve CD8 population (Fig 4C).  Even 
though Stat4 is not required for TGF / IL-6 to induce Tc17 cells (Fig 11A), it is 
still unknown whether Stat4 is important for IL-23 mediated Tc17 development. 
 
The development of IFN- secreting CTLs is mediated through TCR induction of 
Eomes and T-bet.  IL-12 activation of Stat4 further augments the potential for 
IFN- secretion and promotes memory development of Tc1 cells.  In the absence 
of Stat4, IFN- production from Tc1 cells is greatly decreased despite similar 
expression of T-bet and higher expression of Eomes (Fig 19) suggesting that 
Stat4 acts in a non-redundant fashion with T-bet and Eomes to promote IFN- 
production.  In contrast to IFN- expression from CD4 T cells, Stat1 is not 
necessary for optimal Tc1 development (Casey and Mescher, 2007 and Fig 11).  
Instead, the main role described for Stat1 in CD8 T cells has been in inhibiting 
CD8 T cell clonal expansion and promoting their contraction (Quigley et al., 
2008).  Our experiments also show that Stat1 functions to inhibit the Tc17 
phenotype. 
 
Stat proteins and master regulators not only promote the acquisition of cytokine 
secreting potentials, but also crossregulate T cell subsets to control various 
stages of the immune response and the immune response to different classes of 
pathogens.  CD8 T cells which primarily produce IFN- after stimulation instead 
produce IL-17 in the absence of the critical CTL transcription factors Eomes and 
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T-bet (Intlekofer et al., 2008).  This is associated with expression of the IL-17 
transcription factor RORt and a lack of cytotoxic activity from these cells.  
Conversely, CD8 T cells which are differentiated to produce IL-17 instead convert 
to a CTL phenotype and upregulate IFN-, Eomes, and T-bet in the absence of 
the critical Tc17 transcription factor Stat3.  In addition, CTL associated proteins 
are not induced in conditions which induce IL-17 (Figs 7C, 8).   
 
However, our overexpression studies suggest that factors in addition to Eomes, 
T-bet and Stat3 are involved in the crossregulation of IFN- and IL-17 secreting 
CD8 T cells.  Overexpression of Stat3 is only able to reduce IFN-, but not 
granzyme B and overexpression of RORt only slightly reduces granzyme B 
levels (Fig 13).  Overexpression of Eomes and T-bet in Tc17 cells is also unable 
to completely suppress Tc17 programming and induce CTL cells (Fig 22).   
 
Additional candidates to suppress Tc17 programming and induce CTL cells could 
include Stat1 and Stat4.  Experiments with cells lacking Stat1 displayed 
increased IL-17 expression (Fig 11).  In addition, IL-6 activates both Stat1 and 
Stat3 (Gerhartz et al., 1996) and despite Stat3 activation, only induces Tc17 cells 
in the presence of TGF.  One possibility is that Stat1 is inhibiting activation of 
Stat3 and TGF relieves this inhibition since TGF has been shown to inhibit 
Stat1 function in epithelial cells (Reardon and McKay, 2007) and macrophages 
(Takaki et al., 2006).  Stat4 may also be critical for the Tc17 / Tc1 crossregulation 
and in vitro Tc1 cultures require IL-12 induced Stat4 for optimal IFN- production.  
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One possibility is that Stat4 may be required for overexpressed T-bet or Eomes 
to induce optimal expression of IFN- in Tc17 cells as it is in CD4 cells where T-
bet requires Stat4 to induce optimal IFN- production (Thieu et al., 2008).   
 
Our overexpression studies were performed after 24 hrs of T cell activation.  It is 
also possible that early gene expression is critical for the acquisition of cytokine 
secreting potential and genes expressed at a later time point have less effect in 
determining CD8 T cell fate.  For example, a limited timeframe for CTL inhibition 
is seen when TGF and IL-6 are added to IL-12 induced cultures at different time 
points.  When added at Day 0, TGF and IL-6 suppress T-bet, Eomes, IFN-, and 
granzyme B (Fig 21) and suppression of IFN- is absent when TGF and IL-6 are 
added to Tc1 cultures restimulated after 5 days (Fig 26C).  Huber et al. (2009) 
also demonstrate that RORt overexpression can more significantly upregulate 
IL-17 production under conditions of presumably early reduced Eomes 
expression, specifically cells cultured with IL-6 or IL-21 alone or with TGF (Fig 
8).  In these instances, it is possible that T-bet, Eomes, and Stat1 induced early 
during T cell activation are inhibiting the actions of the overexpressed Tc17 
transcription factors. 
 
Therefore even though Stat3/RORt and Eomes/T-bet are critical transcription 
factors mediating the decision between IL-17 and IFN- production from a CD8 T 
cell, additional factors are likely necessary for optimal subset development.   
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Cytotoxicity of Tc17 cells 
In addition to secreting cytokines, CD8 T cells also mediate their functions 
through direct cell killing.  Tc1 cells secrete IFN- to activate macrophages and 
directly kill recognized targets via granzyme B / Perforin and Fas / FasL mediated 
apoptosis.  Studies have shown conflicting results on the cytotoxic ability of Tc17 
cells.  We and others have demonstrated that Tc17 cells are noncytotoxic 
(Intlekofer et al., 2008; Hamada et al., 2009; Huber et al., 2009), although one 
study showed cytotoxic activity of Tc17 cells (Ciric et al., 2009).  Two differences 
between our study and that of Ciric et al. include different types of cytotoxicity 
assays – Cr51 release vs CFSE based, and also different length of culture for 
Tc17 development – 5 days vs 3 days.  To determine if these differences could 
account for the development of cytotoxic Tc17 cells, we analyzed the cytotoxic 
ability of our Tc17 cells in the assay described by Ciric et al.  We found our Tc17 
cells to be noncytotoxic in the CFSE based assay consistent with our Cr51 
release results.  We also found Tc17 cells to be noncytotoxic after 3 days in 
culture and were unable to determine the reason for the discrepancy in cytotoxic 
phenotypes.   
 
Stability of IL-17 secreting T cells 
Utilizing cytokine enrichment assays, we demonstrated that even after several 
rounds of stimulation, Th17 cells were unstable upon challenge with Th1 or Th2 
instructive cytokines.  Tc17 cells were also found to upregulate IFN- and 
cytotoxic function and downregulate IL-17 expression when challenged with IL-
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12.   This instability explains or correlates with several in vivo observations such 
as the presence of IFN- x IL-17 double producing cells in many disease models.  
Since Th1 cells do not convert to Th17 cells, cells producing both cytokines most 
likely first developed as Th17 cells.  In addition, we find that the induction of IFN- 
in Tc17 cells is dependent on both STAT4 and T-bet.  It is interesting that EAE, 
an autoimmune disease dependent on Th17 cells, is abrogated in the deficiency 
of STAT4 or T-bet, which are not required for the development of Th17 cells.  It is 
possible that the instability of Th17 cells also requires Stat4 and T-bet and the 
Th17Th1 switch is important for the propagation of EAE.  The instability of IL-
17 secreting cells raises the question of whether memory IL-17 secreting cells 
exist.  However, it could also lead to several functional advantages.  First, IL-17 
secreting cells may facilitate proinflammatory cell access to immune privileged 
sites.  IL-17 has been shown to disrupt blood brain barrier tight junctions leading 
to inflammation of the brain (Kebir et al., 2007).  After immune access, 
proinflammatory cells can secrete different cytokines to effectively clear 
pathogens.  Cells secreting both IL-17 and IFN- can also promote a dual 
function of localization and immune mediation.  After pathogen invasion, 
neutrophils are found at the infection site followed by macrophages.  Unstable T 
cells secreting IL-17 and then IFN- may mediate the temporal chemoattraction 
of innate immune cells to more effectively eradicate pathogens.  In addition, 
dysregulated IL-17 responses have been shown to contribute towards 
autoimmune responses.  The reduction of IL-17 secreting potential and 
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acquisition of IFN- secretion could be another mechanism of crossregulation to 
prevent IL-17 mediated pathology.   
 
Effect of IL-17 in vaccinia virus infections 
Clearance of vaccinia virus within the first 2 weeks of infection has mainly been 
attributed to immune cells producing Type I and II Interferons, NK cells, and B 
cell antibody production.  A sublethal vaccinia virus infection of mice with isolated 
deficiencies of any of these mechanisms or immune cells does not cause death 
suggesting that mediators for viral clearance are able to compensate for one 
another (Muller et al., 1994; Huang et al., 1993; Cantin et al., 1999; Bukowski et 
al., 1983; Stitz et al., 1986; Xu et al., 2004).  It is also possible that additional 
cells or cytokines, such as IL-17, have a role in vaccinia virus clearance which is 
masked by more dominant mechanisms.  Previous reports analyzing the roles of 
cytokines in vaccinia virus infection have predominantly utilized recombinant 
vaccinia viruses expressing the cytokines of interest.  These studies have made 
significant contributions to our understanding of the immune response to vaccinia 
virus, but have significant limitations.  One limitation is that the level of cytokine 
expression may not correlate with physiological levels induced upon infection and 
cytokine expression cannot be separated from the infectious dose of virus.  This 
can lead to nonphysiological or inconsistent cytokine expression and different 
immune responses.  For example, in a model of tumor immunity, low IL-17 
production is beneficial to the tumor by mechanisms including 
neovascularization.  In contrast, high levels of IL-17 recruit innate immune cells 
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to the tumor site to promote tumor clearance.  Therefore we chose alternative 
methods instead of recombinant cytokine expressing vaccinia viruses.  Upon 
characterizing Tc17 cells in vitro, we determined the potential role of Tc17 cells in 
vaccinia virus in vivo utilizing gene deficient mice and adoptive transfer of Tc17 
cells.   
 
Altered IL-17 levels and vaccinia virus clearance 
By analyzing vaccinia virus clearance from mice with altered IL-17 production, we 
did not find a clear correlation between IL-17 production and viral clearance, 
suggesting that a complex immune response to vaccinia which could be masking 
the role of IL-17.  Il17-/- mice had a trend towards increased viral clearance upon 
infection with a sublethal dose of vaccinia virus.  In contrast, Kohyama et al.  
(2007) reported decreased viral clearance with a lethal dose of vaccinia virus.  
The contradictory results could be due to the different doses used since a lethal 
viral dose could lead to nonphysiological immune responses caused by the 
increased release of cytokines into the bloodstream.  In our experiments, we also 
observed increased IFN- production from CD8 T cells of infected Il17-/- mice 
which is likely contributing to the increased viral clearance.  A recent report has 
demonstrated that IL-17 inhibits NK cell activity in a mouse model of eczema 
vaccinatum (Kawakami et al., 2009) suggesting that increased NK cell activity 
could also be contributing to increased viral clearance in our Il17-/- mice.   
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Clearance of vaccinia virus in mice deficient in IL-17 was also examined using 
Stat3CD4-/- mice.  These mice have a conditional deletion of Stat3 in all T cells 
leading to defective T cell IL-17 production.  Stat3CD4-/- had an increased trend in 
vaccinia titers during early time points and infected mice also had an increased 
trend in weight loss (data not shown) suggesting that IL-17 may contribute to 
vaccinia clearance.  Interestingly, the trend in increased viral titers was seen 
despite increased IFN- production from CD4 cells in the Stat3 deficient mice.  IL-
17F and IL-21 production was also decreased in these mice.  Stat3 is involved in 
several signaling pathways in T cells – IL-27 and IL-6 induction of IL-10 
(Stumhofer et al., 2007), upregulation of CD25 (Akaishi et al., 1998) and SOCS3 
(Qin et al., 2009), and Stat3CD4-/- mice have been observed to have increased 
inducible Foxp3+ regulatory T cells (Sehra, unpublished).  Therefore, multiple 
factors could contribute to the increased vaccinia virus titers seen in these mice.   
 
We also found decreased vaccinia virus clearance in mice with elevated 
expression of IL-17 due to a deficiency in T-bet.  This is consistent with a report 
by Matsui et al. demonstrating that an absence of T-bet impairs VV-specific CTL 
function and IFN- production, and cytolytic function of NK cells.  T-bet deficiency 
also leads to a partial shift in CD4 T cells to a Th2 like phenotype which had 
been attributed as a mechanism for viral survival (Matsui et al., 2005).  Our data 
indicate that increased IL-17 may also contribute to viral survival in Tbx21-/- mice.   
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Tc17 cells 
Adoptive cell transfer allowed us to directly analyze the antiviral potential of IL-17 
secreting CD8 T cells.  We found that transferred Tc17 cells were antiviral 
towards vaccinia virus, upregulated T-bet and IFN-, and acquired cytotoxic 
potential without upregulation of granzyme B.  Antiviral function of Tc17 cells was 
independent of IFN- (Fig 46) and Stat4 (data not shown).  We observed 
reduction of viral titers within 3 days after adoptive cell transfer making viral 
clearance by antibodies an unlikely mechanism during this short time period and 
the role of NK cells was not examined.  IL-17 has been proposed to mediate 
immunity through neutrophil attraction, however, we did not observe neutrophilia 
upon transfer of Tc17 cells.  In addition to acquiring cytotoxic potential, several 
other mechanisms could contribute to viral clearance by transferred Tc17 cells.  
Hamada et al. have suggested that Fas-FasL interactions play a role in Tc17 
mediated clearance of influenza virus (personal communication).  Indeed, we 
found that Tc17 cells upregulate FasL upon a second round of culture with IL-12 
(data not shown).  Tc17 cells also express TNF which is important for viral 
clearance as suggested by the presence of a soluble TNF receptor in some 
strains of vaccinia virus (Reading et al., 2002).  In addition, antimicrobial peptides 
have been shown to contribute to vaccinia virus killing (Howell et al., 2004).  IL-
22 upregulates antimicrobial peptides (Kolls et al., 2008) and IL-22 production 
from Tc17 cells could contribute to vaccinia clearance.   
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Several studies have observed upregulation of IFN- in IL-17 secreting T cells 
adoptively transferred into various disease models.  Bending et al. (2009) and 
Martin-Orozco et al. (2009) both demonstrate that diabetes progression is 
dependent on IFN- and not IL-17 after transfer of Th17 cells.  Muranski et al. 
(2008) demonstrate a dependence on IFN- production from Th17 cells in 
eradication of an established melanoma.  Muranski et al. also show a survival 
advantage of transferred Th17 cells compared to Th1 and Th0 cells.  With 
respect to Tc17 cells, Hamada et al. (2009) demonstrate that Tc17 cells mediate 
survival in an influenza virus infection in an IFN- dependant mechanism.  
Hinrichs et al. (2009) show conversion of Tc17 cells into Tc1 cells, but attribute 
increased Tc17 mediated melanoma clearance to increased persistence of Tc17 
cells compared to Tc1 cells.  Ciric et al. (2009) do not examine IFN- production 
and demonstrate that Tc17 cells mediate diabetes in an IL-17 dependant 
mechanism.  In our model, Tc17 cells mediated vaccinia clearance in an IFN- 
independent mechanism and we demonstrate a novel cytotoxic potential of Tc17 
cells after viral encounter in vivo.  In these disease models, it is also possible that 
both IL-17 and IFN- contribute, and effects of one or both cytokines are masked 
by more dominant immune functions.  In contact hypersensitivity responses, IL-
17 and IFN- secreting CD8 T cells are both able to mediate the delayed type 
cellular response by recruiting distinct cellular infiltrates and having distinct 
potentials in inducing reactive oxygen species.  Altogether, these studies suggest 
that the enhanced survival and unique ability of IL-17 secreting T cells to secrete 
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both IFN- and IL-17 allow them to be potent inflammatory cells contributing to 
the immune response in several disease states.   
 
Tc2 cells and vaccinia virus 
Even though Tc17 cells gain cytotoxicity and mediate viral clearance in vivo, they 
are noncytotoxic in vitro similar to other CD8 T cell subsets such as Tc2 cells.  
Both cell types are activated by viral antigens, however the role of Tc2 cells in 
vaccinia virus clearance is unknown.  In a model of viral infection utilizing 
influenza virus, Tc2 cells were found to be less cytotoxic than Tc1 cells due to 
decreased chemoattraction (Cerwenka et al., 1999).  In contrast, larger numbers 
of Tc17 cells were found in the draining lymphoid organs during our experiments.  
Additional studies exploring the mechanism of action of CD8 subsets in vivo 
could determine if Tc2 cells are also able to mediate vaccinia virus clearance. 
 
Routes of viral inoculation and the immune response 
The natural route of infection for vaccinia virus is the respiratory tract (Fenner et 
al., 1989), although several models have been developed to study the use of 
vaccinia virus as a vaccine vector and to better understand the immune response 
to vaccinia virus.  In addition to the intranasal route of infection; intradermal, 
intraperitoneal, and intracranial routes of infection have been utilized (Turner, 
1967; Buller et al., 1985; Williamson et al., 1990; Lee et al., 1992; Tscharke and 
Smith, 1999).  However, these routes do not illicit identical immune responses 
since critical VV virulence factors often depend on the route of infection 
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(Tscharke et al., 2002).  Our studies infected mice via i.n. and i.p. routes and 
found that adoptively transferred Tc17 cells mediated antiviral immunity through 
both routes while highlighting important observations.  First, i.n. infection led to 
increased immunogenicity and larger amounts of cytokines being produced.  This 
could be due to the virus having a higher potency in a more localized 
environment or to the innate cells in these environments having different priming 
capabilities.  This is in contrast to a previous study which showed that CTL cells 
were impaired in the lung compared to the spleen after i.n. infection (DiNapoli et 
al., 2008).  However,  T cells, CD8 dendritic cells and alveolar macrophages 
have also been shown to be important in VV clearance and it is possible that 
these innate cells have differential effects on CTL vs Tc17 development at these 
sites (Selin et al., 2001; Belz et al., 2004; Rivera et al., 2007).  A second 
observation noted was that during an i.n. infection, more Tc17 cells were 
recruited or proliferated in the draining lymph nodes compared to Tc1 cells while 
similar numbers were found in the spleen.  It is possible that Tc17 cells have an 
intrinsic proliferation advantage or decrease in apoptosis since more Tc17 cells 
were also found in the spleen after an i.p. infection.  Another possiblility is that 
Tc17 cells express higher levels of chemokine receptors to migrate to sites of 
infection.  Even though adoptively transferred Tc17 cells were antiviral regardless 
of route, the route of infection may be critical in future experiments studying 
endogenous Tc17 cells.   
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IL-21 and Tc17 cells 
Recent studies (Elsaesser et al., 2009; Frohlich et al., 2009; Yi et al., 2009) have 
demonstrated that IL-21 is an important cytokine necessary to sustain long term 
function of CD8 T cells.  IL-21 prevents CD8 T cell exhaustion and is proposed to 
be one of the critical elements that allow CD4 T cells to help CD8 T cells combat 
chronic viral infection.  Production of IL-21 by Tc17 cells raises the possibility that 
Tc17 cells may be uniquely suited to combat chronic viral infections – either 
through autocrine IL-21 signaling or paracrine IL-21 signaling towards IFN- 
secreting CD8 T cells.  It is unclear how IL-21 prevents exhaustion, however, 
autocrine IL-21 signals may also lead to greater clonal expansion and memory 
generation of Tc17 cells.  In addition, Tc17 cells could utilize their unstable 
phenotype to prevent exhaustion in IFN- secreting CD8 T cells which once 
secreted IL-17.  Exhaustion of CD8 T cells was first described with LCMV (Zajac 
et al., 1998), and has also been seen in animal models of adenovirus (Krebs et 
al., 2005) and human chronic infections such as HIV (Shankar et al., 2000), HCV 
(Gruener et al., 2001), and HBV (Reignat et al., 2002).  The role of Tc17 cells in 
these models is currently unknown.  Interestingly, Stat3 is critical for both IL-21 
signaling and Tc17 development suggesting that Tc17 cells may have an intrinsic 
ability to prevent exhaustion.    
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OVERALL CONCLUSION 
CD8+ T cells that secrete IFN- and cytotoxic molecules have been well 
characterized and function to mediate antiviral immunity, however, IL-17-
secreting CD8+ T cells are only beginning to be described. Using in vitro T cell 
cultures and mice deficient in transcription factors regulating lineage 
development, our studies defined Tc17 development and function.  Similar to 
Th17 cells, Tc17 development is dependent on the transcription factor Stat3 and 
inhibited by Stat1.  Compared to Tc1 cells, expression of T-bet and Eomes is 
reduced in Tc17 cells and consistent with this, Tc17 cells are non-cytotoxic in 
vitro. However, Tc17 cells exhibit plasticity and switch to cytotoxic IFN- 
producing cells when exposed to a Tc1 inducing cytokine, IL-12.  Overexpression 
of the lineage promoting transcription factors T-bet and Eomes is unable to 
induce a Tc1 phenotype in Tc17 cells and Stat3 is also unable to switch Tc1 cells 
into Tc17 cells, suggesting additional signals are involved in CD8 T cell lineage 
commitment.  Experiments utilizing a vaccinia virus infection model demonstrate 
that Tc17 cells mediate antiviral immunity in vivo and acquire a novel phenotype 
after viral encounter with the potential to secrete IFN- and mediate direct cell 
cytotoxicity.  However, IFN- secretion is not necessary for vaccinia clearance by 
Tc17 cells and the role of cell mediated cytotoxicity is still unclear.  These data 
suggest that Tc17 cells may mediate anti-viral immunity through novel 
mechanisms that depend on the ability of Tc17 cells to acquire other phenotypes. 
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FUTURE DIRECTIONS 
Are endogenous Tc17 cells necessary for vaccinia virus clearance? 
Even though CD8 cells are dispensable during primary vaccina virus clearance, 
they are critical for anti-vaccinia defense in the absence of CD4 T cells.  
However, it is unknown whether these CD8 T cells require IL-17 to mediate their 
function.  Our experiments utilizing gene knockout mice with altered levels of IL-
17 did not show a clear relationship between IL-17 and viral clearance or 
discriminate between IL-17 secretion by CD4 or CD8 T cells.  To determine the 
role of endogenous IL-17 secreting CD8 T cells in vaccinia virus infection, first, a 
correlation could be determined utilizing infected mice deficient in CD4 T cells 
(either through antibody depletion or genetic deficiency such as CIITA-/- or A-/-
mice) and characterizing the cytokine response from the CD8 T cells.  Next, mice 
lacking both CD4 and CD8 T cells, such as Rag-/- mice, could be infected and 
various cytokine deficient CD8 T cells adoptively transferred.  Another strategy to 
determine if IL-17 producing cells are necessary for anti-vaccinia defense would 
utilize infected Stat3CD4-/- mice and adding back WT CD4 and CD8 T cell 
populations to determine which IL-17 secreting population promotes optimal viral 
clearance.   
 
Are Tc17 cells intrinsically unstable and how do they mediate viral 
protection? 
Tc17 cells convert to IFN- secreting CD8 cells when stimulated in the presence 
of IL-12 in vitro.  In addition, Tc17 cells transferred into a virally infected mouse 
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acquire a cytotoxic phenotype as they mediate viral clearance.  There are at least 
4 possibilities for the requirements necessary to convert Tc17 cells to a cytotoxic 
phenotype – 1) Tc17 cells alter their phenotype upon homeostatic proliferation, 2) 
viral antigen is required for conversion, 3) an inflammatory milieu is required for 
conversion, 4) or both antigen and inflammatory cytokines are required.  
Determining the requirements for the transition of the Tc17 phenotype would 
provide insight into the mechanism of viral clearance by adoptively transferred 
Tc17 cells.  If Tc17 cells require any combination of viral antigens or 
inflammatory cytokines to become cytotoxic, it is likely that this cytotoxic 
phenotype is necessary for viral clearance.  Further in vitro cytotoxicity assays or 
in vivo infection experiments utilizing antibody neutralization or genetically 
deficient cells could determine which cytotoxic mediators – for example 
granzyme B, perforin, FasL, TNF, or a novel cytotoxic molecule – are 
responsible for Tc17 mediated cytotoxicity.  On the other hand, if Tc17 cells are 
intrinsically unstable, it would suggest that the cytotoxic phenotype is a byproduct 
of the Tc17 life cycle and raise the possibility that molecules involved in the Tc17 
phenotype – such as IL-21 and IL-22 are responsible for Tc17 mediated viral 
clearance.  These experiments can be performed utilizing transferred Tc17 cells 
and bone marrow derived dendritic cells either infected with vaccinia virus or 
uninfected and analyzing subsequent Tc17 phenotypes.  Since Stat4-/- x Tbx21-/- 
double knockout CD8 cells maintain a Tc17 phenotype in vitro, antigen specific 
double knockout cells could also be utilized to answer a similar question of 
whether conversion of the Tc17 phenotype is necessary for viral clearance. 
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